Cypherpunk Technologies posts $306M Q3 2026 profit
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Cypherpunk Technologies Inc. (CYPH) reported third-quarter 2026 net income of $306.005 million, versus a $3.303 million loss a year earlier. The quarter included a $330.846 million unrealized gain on an embedded derivative. Mining revenue was $9.913 million, versus none in 2025; mining compensation is received in ZEC, not cash. Nine-month net income was $268.228 million, while operating cash used was $9.024 million.
At September 30, 2026, the company held 332,361.67 ZEC and reported $470.146 million of digital assets receivable and $55.988 million in cash and cash equivalents. It believes cash and its ability to raise capital under the $200 million Cantor sales agreement will cover operating expenses for at least 12 months from issuance.
Cypherpunk Mining acquired mining equipment, hosting agreements and deposits for a $33.333 million purchase price, paid with a pre-funded warrant to Winklevoss Capital for 43,290,042 shares at a $0.001 exercise price. Before stockholder approval, no more than 5,377,442 shares may be exercised; the warrant also has a 19.99% beneficial ownership limit. A non-binding Bitmain letter of intent covers up to $30 million of machines and a refundable $6 million deposit; purchase requires a definitive agreement, with delivery expected in mid-2027.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointThird-quarter net income was $306.005 million, including a $330.846 million unrealized gain.
- Moderate pointMining revenue was $9.913 million versus none in the year-ago quarter.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Exercise of the 43,290,042-share warrant carries the company’s stated substantial-dilution risk.
Key Figures
Key Terms
embedded derivative financial
digital assets receivable financial
Pay-Per-Share Plus technical
hashrate technical
pre-funded warrant financial
Simple Agreement for Future Equity financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was CYPH’s net income in third-quarter 2026?
How much ZEC did CYPH hold at September 30, 2026?
What are the terms of CYPH’s mining fleet acquisition warrant?
Is CYPH’s planned Bitmain mining-machine purchase binding?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number:

(Exact name of registrant as specified in its charter)
| | |
| |
|
| | |
| |
|
| | |
(
Registrant’s Telephone Number, Including Area Code
N/A
Former Name, Former Address and Former Fiscal Year, if Changed
Since Last Report Securities registered pursuant to Section 12(b) of the Act:
Title of each class: | | Trading Symbol(s) | | Name of each exchange on which registered: |
| |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ | | Accelerated filer ☐ |
| | |
| Smaller reporting company | |
| | |
| | Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
As of November 12, 2026, there were
TABLE OF CONTENTS
| | Page |
PART I — FINANCIAL INFORMATION | | |
| | |
Item 1 | Financial Statements | 6 |
| | |
Item 2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 31 |
| | |
Item 3 | Quantitative and Qualitative Disclosures About Market Risk | 43 |
| | |
Item 4 | Controls and Procedures | 43 |
| | |
PART II — OTHER INFORMATION | | |
| | |
Item 1 | Legal Proceedings | 45 |
| | |
Item 1A | Risk Factors | 45 |
| | |
Item 2 | Unregistered Sales of Equity Securities and Use of Proceeds | 51 |
| | |
Item 3 | Defaults Upon Senior Securities | 51 |
| | |
Item 4 | Mine Safety Disclosures | 51 |
| | |
Item 5 | Other Information | 51 |
| | |
Item 6 | Exhibits | 52 |
2
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA
This Quarterly Report on Form 10-Q (this “Quarterly Report”) contains forward-looking statements which reflect our current views with respect to, among other things, our operations and financial performance. Such statements are based upon our current plans, estimates and expectations that are subject to various risks and uncertainties that could cause actual results to differ materially from such statements. The inclusion of forward-looking statements should not be regarded as a representation that such plans, estimates and expectations will be achieved. Words such as “anticipate,” “expect,” “project,” “intend,” “believe,” “may,” “will,” “should,” “plan,” “could,” “continue,” “target,” “contemplate,” “estimate,” “forecast,” “guidance,” “predict,” “possible,” “potential,” “pursue,” “likely,” and words and terms of similar substance used in connection with any discussion of future plans, actions or events identify forward-looking statements.
Forward-looking statements address various matters including statements relating to the value of Cypherpunk Technologies Inc.’s (the “Company”) ZEC holdings, the Company’s investment in Zcash Open Development Lab (“ZODL”), the expected future market, price, and liquidity of ZEC or other digital assets the Company acquires or mines, the Company’s Zcash mining operations, including expected hashrate, production of ZEC, fleet uptime, hosting and power costs, the performance of the Company’s mining machines, mining pool and hosting providers, and the delivery, timing, cost, and performance of additional mining machines, anticipated changes to the Zcash protocol, the macro and political conditions surrounding Zcash or digital assets, the Company’s plan for value creation and strategic advantages, market size and growth opportunities, regulatory conditions, competitive position, and the interest of other corporations in similar business strategies, technological and market trends, and the Company’s future financial condition and performance. Risks and uncertainties of the Company’s Privacy Technology segment include, among others: (a) risks relating to the Company’s operations and business, including the highly volatile nature of the price of ZEC; (b) the risk that material changes in the price of ZEC, such as decreases in price, will result in significant changes to the Company’s financial statements, such as unrealized losses on fair value of ZEC holdings and net loss; (c) the risk that the price of the Company’s common stock may be highly correlated to the price of ZEC; (d) the risk that we will fail to realize the anticipated benefits of the ZEC digital asset treasury strategy or the investment in ZODL; (e) risks related to the custody of the Company’s ZEC and the Company’s reliance on Gemini Space Station and its affiliates for trading and custody services; (f) changes in business, market, financial, political, and regulatory conditions; (g) risks related to increased competition in the industries in which we currently operate and may operate in the future; (h) risks relating to significant legal, commercial, regulatory, and technical uncertainty regarding digital assets generally; (i) risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; (j) the risk that the Company’s mining revenue, which depends on the price of ZEC, total Zcash network hashrate, the block subsidy and transaction fees and the performance of the mining pool we use, will be highly volatile and may not cover the Company’s hosting, power and other mining costs, which are payable in U.S. dollars; (k) the Company’s dependence on third-party hosting providers for the power, infrastructure, security, and operation of all of the Company’s mining machines, and the risk of power cost increases, curtailment, outages, and other events at its hosting sites; (l) the Company’s reliance on a single manufacturer, which exposes us to several risks, including the risk of technological obsolescence as more efficient machines are deployed on the Zcash network, and the risk that we do not receive next-generation machines on the timetable, at the price, or with the performance we expect, or at all; (m) changes to the Zcash protocol, including the scheduled halving of the block subsidy and the effects of the NU7 network upgrade activated in November 2026, which could reduce the value of the Company’s mining machines; (n) risks related to the Mining Asset Acquisition (as defined below) (o) the risk of substantial dilution to existing stockholders upon the exercise of the pre-funded warrant issued as consideration in connection with the Mining Asset Acquisition; and (p) regulatory, tax, energy, and environmental risks applicable to digital asset mining.
With respect to our Biotechnology Segment, important factors that could cause actual results to differ materially from our plans, estimates or expectations could include, but are not limited to: (i) the fact that the DeFianCe study did not meet its prespecified primary endpoint of progression-free survival in the intent-to-treat population; (ii) the fact that the DKK1 biomarker subgroup and interaction analyses were exploratory, were based on a limited number of patients, were not adjusted for multiplicity, and may not be replicated in a prospective clinical trial; (iii) the impact of imbalances between treatment arms in the DKK1 subgroups; (iv) the risk that alignment with the FDA on trial design does not constitute agreement that any trial will succeed or that any marketing application will be accepted or approved, and the FDA may change its position at any time; (v) the fact that accelerated approval, if pursued, requires that the surrogate endpoint be reasonably likely to predict clinical benefit and is subject to confirmatory trial requirements and possible withdrawal if such requirements are not satisfied; (vi) our ability to initiate or complete the Phase 3 trial on the anticipated timeline or at all; (vii) our ability to obtain additional capital to advance sirexatamab on acceptable terms or at all; (viii) the risk that the strategic process may not result in any transaction or financing, may be terminated at any time, and any resulting transaction may not be on terms favorable to us or our stockholders; (ix) our ability to develop and validate a companion diagnostic; (x) the success of competing therapies; (xi) our ability to secure manufacturing capacity for sirexatamab; and (xii) our ability to maintain and protect our intellectual property rights.
3
By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. Although we believe that we have a reasonable basis for each forward-looking statement contained in this Quarterly Report, we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate may differ materially from the forward-looking statements contained in this Quarterly Report. In addition, even if our results of operations, financial condition and liquidity, and events in the industry in which we operate are consistent with the forward-looking statements contained in this Quarterly Report, they may not be predictive of results or developments in future periods. You should carefully and completely read this Quarterly Report and the documents that we have filed as exhibits to this Quarterly Report.
You should refer to Part II, Item 1A, Risk Factors in this Quarterly Report and Part I, Item 1A, Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission on March 16, 2026, for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. If our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard any such statement as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified timeframe, or at all. Any forward-looking statement that we make in this Quarterly Report speaks only as of the date of such statement, and, except to the extent required by applicable law, we undertake no obligation to update such statements to reflect events or circumstances after the date of this Quarterly Report or to reflect the occurrence of unanticipated events. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this Quarterly Report. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.
Sirexatamab (DKN-01) is an investigational drug undergoing clinical development and has not been approved by the FDA, nor has it been submitted to the FDA for approval. Sirexatamab has not been, and may never be, approved by any regulatory agency or marketed anywhere in the world. Statements contained in this Quarterly Report should not be deemed to be promotional.
4
INTRODUCTORY COMMENT
References to Cypherpunk and Leap
On November 12, 2025, we filed a charter amendment with the Secretary of State of the State of Delaware changing the Company’s name from “Leap Therapeutics, Inc.” to “Cypherpunk Technologies Inc.”. In connection with the name change, the Company formed a new wholly-owned subsidiary, named “Leap Therapeutics, Inc.”, which conducts the biotechnology operations of the Company.
Throughout this Quarterly Report on Form 10-Q, the “Company,” “Cypherpunk”, “Cypherpunk Technologies”, “we,” “us,” and “our,” except where the context requires otherwise, refer to Cypherpunk Technologies Inc. and its consolidated subsidiaries, and, except where the context requires otherwise, “Board of Directors” refers to the board of directors of Cypherpunk Technologies Inc. References to “Leap” and “Leap Therapeutics” refer to Leap Therapeutics, Inc., and may include drug development activities that took place prior to Leap’s incorporation on November 12, 2025. For purposes of clarity and differentiation between the two business strategies, we may refer to “Cypherpunk” when discussing our privacy technology and digital asset treasury business and to “Leap” when discussing our cancer drug development business.
5
Part I – FINANCIAL INFORMATION
Item 1. Financial Statements
CYPHERPUNK TECHNOLOGIES INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
| | September 30, | | December 31, | ||
| | 2026 | | 2025 | ||
Assets |
| | |
| | |
Current assets: |
| | |
| | |
Cash and cash equivalents | | $ | | | $ | |
Digital assets receivable | | | | | | |
Research and development incentive receivable | |
| — | |
| |
Prepaid expenses and other current assets | |
| | |
| |
Total current assets | |
| | |
| |
| | | | | | |
Property and equipment, net | |
| | |
| — |
Right of use assets, net | | | | | | |
Deferred costs | | | | | | |
Deposits | |
| | |
| |
Other investment | | | | | | — |
Total assets | | $ | | | $ | |
| | | | | | |
Liabilities and Stockholders’ Equity | |
| | |
| |
Current liabilities: | |
| | |
| |
Accounts payable | | $ | | | $ | |
Accrued expenses | |
| | |
| |
Income tax payable | | | | | | |
Lease liability | | | | | | |
Total current liabilities | | | | | | |
| | | | | | |
Non-current liabilities: | | | | | | |
Deferred tax liability | | | | | | |
Total liabilities | | | | | | |
| | | | | | |
Stockholders’ equity: | | | | | | |
Preferred stock, $ | | | — | | | — |
Common stock, $ | | | | | | |
Stock subscription receivable | | | — | | | ( |
Additional paid-in capital | |
| | |
| |
Accumulated other comprehensive loss | |
| ( | |
| ( |
Accumulated deficit | |
| ( | |
| ( |
Total stockholders’ equity | |
| | |
| |
Total liabilities and stockholders’ equity | | $ | | | $ | |
See notes to condensed consolidated financial statements.
6
CYPHERPUNK TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)
(Unaudited)
| | Three Months Ended September 30, |
| Nine Months Ended September 30, | ||||||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
Mining revenue | | $ | | | $ | — | | $ | | | $ | — |
| | | | | | | | | | | | |
Operating costs and expenses: | | | | | | | | | | | | |
Cost of revenue (excluding depreciation and amortization) | | | | | | — | | | | | | — |
Research and development | |
| | |
| | |
| | |
| |
General and administrative | | | | | | | | | | | | |
Depreciation and amortization | |
| | |
| — | |
| | |
| — |
Restructuring charges | |
| — | |
| — | |
| — | |
| |
Total operating costs and expenses | |
| | |
| | |
| | |
| |
Income (loss) from operations | | | | | | ( | | | ( | | | ( |
Interest income | |
| | |
| | |
| | |
| |
Interest expense | | | ( | | | ( | | | ( | | | ( |
Australian research and development incentives | | | — | | | ( | | | — | | | — |
Change in fair value of embedded derivative | | | | | | — | | | | | | — |
Foreign currency gains | | | — | | | | | | | | | |
Income (loss) before income taxes | | | | | | ( | | | | | | ( |
Provision for income taxes | | | ( | | | ( | | | ( | | | ( |
Net income (loss) attributable to common stockholders | | $ | | | $ | ( | | $ | | | $ | ( |
| | | | | | | | | | | | |
Net income (loss) per share | | | | | | | | | | | | |
Basic | | $ | | | $ | ( | | $ | | | $ | ( |
Diluted | | $ | | | $ | ( | | $ | | | $ | ( |
| | | | | | | | | | | | |
Weighted average common shares outstanding | | | | | | | | | | | | |
Basic | | | | | | | | | | | | |
Diluted | | | | | | | | | | | | |
See notes to condensed consolidated financial statements.
7
CYPHERPUNK TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
(Unaudited)
| | Three Months Ended September 30, | | Nine Months Ended September 30, | ||||||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
Net income (loss) | | $ | | | $ | ( | | $ | | | $ | ( |
Other comprehensive income (loss): | |
| | | | | | | | |
| |
Foreign currency translation adjustments | | | | |
| ( | | | | |
| |
Comprehensive income (loss) | | $ | | | $ | ( | | $ | | | $ | ( |
See notes to condensed consolidated financial statements.
8
CYPHERPUNK TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
For the Three and Nine Months Ended September 30, 2026
(In thousands, except share amounts)
(Unaudited)
| | | | | | | | | | | | | Accumulated | | | | | | | |
| | | | | | | Stock | | Additional | | Other | | | | | Total | ||||
| | Common Stock | | Subscription | | Paid-in | | Comprehensive | | Accumulated | | Stockholders’ | ||||||||
| | Shares | | Amount | | Receivable | | Capital | | Loss | | Deficit | | Equity | ||||||
Balances at June 30, 2026 | | | | $ | | | $ | — | | $ | | | $ | ( | | $ | ( | | $ | |
Issuance of common stock through ATM sales | | | | | | | | — | | | | | | — | | | — | | | |
Issuance of prefunded warrants in connection with the acquisition of assets from Moria | | — | | | — | | | — | | | | | | — | | | — | | | |
Amortization of ATM issuance costs | | — | | | — | | | — | | | ( | | | — | | | — | | | ( |
Issuance of common stock upon exercise of stock options | | | | | — | | | — | | | | | | — | | | — | | | |
Issuance of common stock upon exercise of prefunded warrants | | | | | | | | — | | | — | | | — | | | — | | | |
Foreign currency translation adjustment | | — | | | — | | | — | | | — | | | | | | — | | | |
Stock-based compensation | | — | | | — | | | — | | | | | | — | | | — | | | |
Net income | | — | | | — | | | — | | | — | | | — | | | | | | |
Balances at September 30, 2026 | | | | $ | | | $ | — | | $ | | | $ | ( | | $ | ( | | $ | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | Stock | | Additional | | Other | | | | | Total | ||||
| | Common Stock | | Subscription | | Paid-in | | Comprehensive | | Accumulated | | Stockholders’ | ||||||||
| | Shares | | Amount | | Receivable | | Capital | | Loss | | Deficit | | Equity | ||||||
Balances at December 31, 2025 |
| | | $ | | | $ | ( | | $ | | | $ | ( | | $ | ( | | $ | |
Issuance of common stock through ATM sales | | | | | | | | — | | | | | | — | | | — | | | |
Issuance of prefunded warrants in connection with the acquisition of assets from Moria | | — | | | — | | | — | | | | | | — | | | — | | | |
Amortization of ATM issuance costs | | — | | | — | | | — | | | ( | | | — | | | — | | | ( |
Issuance of common stock upon exercise of stock options | | | | | — | | | — | | | | | | — | | | — | | | |
Issuance of common stock upon exercise of prefunded warrants | | | | | | | | — | | | — | | | — | | | — | | | |
Issuance of common stock upon vest of restricted stock units | | | | | | | | — | | | ( | | | — | | | — | | | — |
Collection of stock subscription receivable related to ATM share issuances | | — | | | — | | | | | | — | | | | | | — | | | |
Foreign currency translation adjustment | | — | | | — | | | — | | | — | | | | | | — | | | |
Stock-based compensation | | — | | | — | | | — | | | | | | — | | | — | | | |
Net income |
| — | |
| — | | | — | |
| — | |
| — | |
| | |
| |
Balances at September 30, 2026 |
| | | $ | | | $ | — | | $ | | | $ | ( | | $ | ( | | $ | |
See notes to condensed consolidated financial statements.
9
CYPHERPUNK TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
For the Three and Nine Months Ended September 30, 2025
(In thousands, except share amounts)
(Unaudited)
| | | | | | | | | | Accumulated | | | | | | | |
| | | | | | | Additional | | Other | | | | | Total | |||
| | Common Stock | | Paid-in | | Comprehensive | | Accumulated | | Stockholders’ | |||||||
| | Shares | | Amount | | Capital | | Loss | | Deficit | | Equity | |||||
Balances at June 30, 2025 | | | | $ | | | $ | | | $ | ( | | $ | ( | | $ | |
Foreign currency translation adjustment | | — | | | — | | | — | | | ( | | | — | | | ( |
Stock-based compensation | | — | | | — | | | | | | — | | | — | | | |
Net loss | | — | | | — | | | — | | | — | | | ( | | | ( |
Balances at September 30, 2025 | | | | $ | | | $ | | | $ | ( | | $ | ( | | $ | |
| | | | | | | | | | Accumulated | | | | | | | |
| | | | | | | Additional | | Other | | | | | Total | |||
| | Common Stock | | Paid-in | | Comprehensive | | Accumulated | | Stockholders’ | |||||||
| | Shares | | Amount | | Capital | | Loss | | Deficit | | Equity | |||||
Balances at December 31, 2024 |
| | | $ | | | $ | | | $ | ( | | $ | ( | | $ | |
Issuance of common stock upon exercise of stock options | | | | | — | | | | | | — | | | — | | | |
Issuance of common stock upon exercise of prefunded warrants | | | | | | | | ( | | | — | | | — | | | — |
Issuance of common stock upon vest of restricted stock units | | | | | — | | | — | | | — | | | — | | | — |
Foreign currency translation adjustment |
| — | | | — | | | — | | | | | | — | | | |
Stock-based compensation |
| — | | | — | | | | | | — | | | — | | | |
Net loss |
| — | |
| — | |
| — | |
| — | |
| ( | |
| ( |
Balances at September 30, 2025 |
| | | $ | | | $ | | | $ | ( | | $ | ( | | $ | |
See notes to condensed consolidated financial statements.
10
CYPHERPUNK TECHNOLOGIES INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
| | | | | | |
| | Nine Months Ended September 30, | ||||
| | 2026 | | 2025 | ||
Cash flows from operating activities: |
| | |
| | |
Net income (loss) | | $ | | | $ | ( |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| | |
| |
Depreciation and amortization | | | | | | — |
Non-cash operating lease expense | |
| — | |
| |
Deferred income taxes | | | | | | — |
Stock-based compensation expense | | | | | | |
Change in fair value of embedded derivative | |
| ( | |
| — |
Mining revenues, net | |
| ( | |
| — |
Foreign currency transaction gains | | | ( | | | ( |
Changes in operating assets and liabilities: | | | | | | |
Prepaid expenses and other assets | | | | | | |
Research and development incentive receivable | | | | | | — |
Accounts payable and accrued expenses | | | ( | | | ( |
Income tax payable | | | ( | | | ( |
Lease liability | | | — | | | ( |
Deposits | | | ( | | | |
Net cash used in operating activities | |
| ( | |
| ( |
| | | | | | |
Cash flows from investing activities: | | | | |
| |
Other investment | | | ( | | | — |
Purchases of digital assets | | | ( | | | — |
Advanced payment for mining equipment | | $ | ( | | | — |
Net cash used in investing activities | |
| ( | |
| — |
| | | | | | |
Cash flows from financing activities: | |
| | |
| |
Proceeds through issuance of common stock through ATM sales, net of fees | | | | | | — |
Collection of stock subscription receivable | | | | | | — |
Payment of deferred offering costs | | | ( | | | — |
Principal payments of insurance financing | | | ( | | | ( |
Proceeds from the exercise of pre-funded warrants | | | | | | — |
Proceeds from the exercise of stock options | | | | | | |
Net cash provided by (used in) financing activities | |
| | |
| ( |
| | | | | | |
Effect of exchange rate changes on cash and cash equivalents | |
| | |
| |
Net increase (decrease) in cash and cash equivalents | |
| | |
| ( |
Cash and cash equivalents at beginning of period | |
| | |
| |
Cash and cash equivalents at end of period | | $ | | | $ | |
| | | | | | |
Supplemental disclosure of non-cash financing activities: | | | | | | |
Pre-funded warrants issued in connection with the Moria asset purchase | | $ | | | $ | — |
Offering costs in accrued expenses | | $ | | | $ | — |
Offering costs from October 2025 PIPE included in accrued expenses | | $ | — | | $ | |
Prepayment of insurance through third-party financing | | $ | | | $ | |
Issuance of common stock upon vest of restricted stock units | | $ | | | $ | — |
Amortization of deferred ATM offering costs | | $ | | | $ | — |
See notes to condensed consolidated financial statements.
11
Cypherpunk Technologies Inc.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except share and per share amounts)
(Unaudited)
1. Nature of Business, Basis of Presentation and Liquidity
Nature of Business
Cypherpunk Technologies Inc. (Nasdaq:CYPH) (“the Company”) was incorporated in the state of Delaware on January 3, 2011. Wholly owned subsidiaries of the Company as of September 30, 2026 include HealthCare Pharmaceuticals Pty Ltd. (“HCP Australia”), Leap Securities Corp., Flame Biosciences LLC (“Flame”), Leap Therapeutics, Inc. and Cypherpunk Mining LLC (“Cypherpunk Mining”).
Historically, the Company has been a biopharmaceutical company developing biomarker-targeted antibody therapies designed to treat patients with cancer. The Company’s clinical stage program is sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. The Company also has a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.
The Company has in the past devoted substantially all its resources to development efforts relating to its product candidates, including manufacturing and conducting clinical trials of its product candidates, providing general and administrative support for these operations and protecting its intellectual property. The Company does not have any therapeutic products approved for sale and has not generated any revenue from biopharmaceutical sales. The Company has funded its operations primarily through proceeds from its sales of common stock and preferred stock and proceeds from the issuance of notes payable.
In October 2025, the Company announced a $
On November 12, 2025, the Company changed its name from “Leap Therapeutics, Inc.” to “Cypherpunk Technologies Inc.” and changed its trading symbol from “LPTX” to “CYPH”. The Company was renamed to Cypherpunk Technologies Inc. to reflect the strategic focus on acquiring ZEC, participating in the development of Zcash, and the values of privacy and liberty. The Company’s ongoing research and development operations are being conducted under a new wholly-owned subsidiary named “Leap Therapeutics, Inc.”, which was incorporated in November 2025.
In August 2026, the Company announced the acquisition of a Zcash mining fleet and the launch of Cypherpunk Mining. Cypherpunk Mining, a wholly-owned subsidiary of the Company, acquired a fleet of Zcash mining machines, the related hosting agreements, and hosting deposits from an affiliate of Winklevoss Treasury Investments, LLC, the Company’s largest shareholder, in exchange for a pre-funded warrant to purchase shares of the Company’s common stock. The Company’s mining equipment is installed at hosting facilities in the United States (“U.S.”) and the ZEC earned through mining is held with the Company’s custodian together with its purchased ZEC.
Basis of Presentation
The December 31, 2025 year-end condensed consolidated balance sheet data in the accompanying interim condensed consolidated financial statements was derived from audited consolidated financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. These condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2025, included in the Company’s Annual Report on Form 10-K filed with the SEC on March 16, 2026.
12
The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on the same basis as the audited consolidated financial statements as of and for the year ended December 31, 2025. In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments which are necessary for the fair presentation of the Company’s financial position as of September 30, 2026, statements of operations and statements of comprehensive income (loss) for the three and nine months ended September 30, 2026 and 2025 and statements of cash flows for the nine months ended September 30, 2026 and 2025. Such adjustments are of a normal and recurring nature. The results of operations for the three and nine months ended September 30, 2026 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2026.
Liquidity
Since inception, the Company has been engaged in organizational activities, including raising capital, and research and development activities. In October 2025, the Company implemented its digital asset treasury strategy and in August 2026, the Company commenced Zcash mining operations. Although the Company reported income from operations for the three months ending September 30, 2026, the Company has never generated positive cash flows from its biopharmaceutical operations. The Company’s mining revenue is received in ZEC rather than cash, while its hosting and other mining costs and operating expenses are paid in cash. The Company does not have a therapeutic product that has been approved by the Food and Drug Administration (the “FDA”). There is no assurance that profitable operations from the Company’s privacy technology/digital asset treasury strategy, Zcash mining operations, or biotechnology research and development operations, if achieved, could be sustained on a continuing basis. Further, the Company’s future operations are dependent on the success of the Company’s efforts to raise additional capital, the success of the privacy technology/digital asset treasury strategy, its biotechnology research and commercialization efforts, regulatory approval, and, ultimately, the market acceptance of the Company’s products.
In accordance with Accounting Standards Codification (“ASC”) 205-40, Going Concern, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. As of September 30, 2026, the Company had cash and cash equivalents of $
The Company believes that its cash and cash equivalents of $
In addition, to support its future expenses, Zcash mining operations and privacy technology/digital asset treasury strategy, the Company will likely seek additional funding through public or private equity or debt financings. The Company has initiated a strategic process to fund its biotechnology operations, through equity investment, funding or development program cost-sharing through collaboration agreements, or licenses with larger pharmaceutical or biotechnology companies. There can be no assurance that the strategic process will be successful and that such capital will be available on acceptable terms or at all. The inability to obtain funding, as and when needed, could have a negative impact on the Company’s financial condition and ability to pursue its business strategies.
2. Summary of Significant Accounting Policies
Principles of Consolidation
The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions are eliminated upon consolidation.
Use of Estimates
The presentation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
13
Revenue Recognition
The Company participates in mining pools operated by third parties. As a participant in the mining pools, the Company provides a service to perform hash calculations for the mining pool, which is an output of its ordinary activities.
The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”). The core principle of the revenue standard is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The following five steps are applied to achieve that core principle: (1) identify the customer contract; (2) identify performance obligations that are distinct; (3) determine the transaction price; (4) allocate the transaction price to the distinct performance obligations; and (5) recognize revenue as the performance obligations are satisfied.
The Company considers the mining pool operators to be its customers under ASC 606. Contract inception and the Company’s enforceable right to consideration begins when the Company commences providing hash calculation services to the mining pool operators. Refer to Note 4 for further information.
Cost of Revenues
Cost of mining revenue consists of the fees the Company pays to its hosting providers under hosting agreements, which are based principally on the electricity consumed by the Company’s machines, and include maintenance and support. Mining pool fees are deducted from the ZEC that the Company receives and is reflected as a reduction of mining revenue rather than as a cost. The Company does not currently purchase electricity directly. Depreciation of the Company’s mining machines is presented separately.
Asset Acquisitions
The Company accounts for acquisitions that do not meet the definition of a business under ASC 805, Business Combinations (“ASC 805”), as asset acquisitions. The cost of an asset acquisition, including direct and incremental transaction costs, is allocated to the assets acquired and liabilities assumed on a relative fair value basis as of the acquisition date. No goodwill is recognized in an asset acquisition. Assets acquired and liabilities assumed are subsequently accounted for under the applicable accounting guidance based on their nature.
Cash and Cash Equivalents
The Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents. Cash equivalents consisted of overnight investments and money market funds.
Digital Assets Receivable
As part of its digital asset strategy, the Company holds digital assets in the form of Zcash with Gemini Space Station LLC and its subsidiaries, as a third-party custodian (collectively, “Gemini”). The Company acquires ZEC through both open market purchases and, beginning in the three months ended September 30, 2026, from its digital asset mining operations. The Company does not control the digital assets for accounting purposes, and the contractual arrangement represents the Company’s enforceable contractual right to receive digital assets from the custodian on demand and is accounted for as a hybrid instrument under ASC 815, Derivatives and Hedging (“ASC 815”). The host contract represents a non-interest bearing receivable collectible on demand and is recorded at the transaction price, representing the fair value of the digital assets at the time of acquisition, and was $
14
The hybrid instrument contains a host receivable and an embedded derivative that is required to be bifurcated because the embedded exposure to changes in the fair value of the underlying digital assets is not clearly and closely related to the economic characteristics of the host receivable. The embedded derivative is subsequently measured at fair value each reporting period, with changes in fair value recorded as an unrealized gain (loss) on change in fair value of embedded derivative in the Consolidated Statement of Operations. During the three and nine months ended September 30, 2026, the Company recorded an unrealized gain on change in fair value of embedded derivative of $
As digital assets receivable is collectible on demand, it is classified as a current asset on the Company’s consolidated balance sheet. As of September 30, 2026, the Company had digital assets receivable of $
Property and Equipment, Net
Property and equipment, net is stated at cost, less accumulated depreciation. Maintenance and repairs are expensed when incurred. Additions and improvements that extend the economic useful life of the assets are capitalized and depreciated over the remaining useful lives of the assets. Costs incurred during construction are capitalized as construction in progress and reclassified to the appropriate categories and depreciated when the project is completed and the assets are placed in service. The cost and accumulated depreciation of assets sold or retired are removed from the respective accounts, and any resulting gain or loss is reflected in current earnings. Depreciation is provided using the straight-line method in amounts considered to be sufficient to amortize the cost of the assets to operations over their estimated useful lives. The Company depreciates its mining equipment on a straight-line basis over an estimated useful life of
Research and Development Expense
Research and development costs are expensed as incurred and are primarily related to the Company’s Biotechnology segment. Research and development expenses include personnel costs associated with research and development activities, including noncash share-based compensation and costs for third-party contractors to perform research, conduct clinical trials and manufacture drug supplies and materials. The Company accrues costs incurred by external service providers, including contract research organizations and clinical investigators, based on its estimates of service performed and costs incurred. These estimates include the level of services performed by the third parties, patient enrollment in clinical trials, administrative costs incurred by the third parties, and other indicators of the services completed. Based on the timing of amounts invoiced by service providers, the Company may also record payments made to those providers as prepaid expenses that will be recognized as expenses in future periods as the related services are rendered.
Research and development incentive income and receivable
The Company recognizes other income from Australian research and development incentives when there is reasonable assurance that the income will be received, the relevant expenditure has been incurred, and the consideration can be reliably measured.
Management has assessed the Company’s research and development activities and expenditures to determine which activities and expenditures are likely to be eligible under the research and development incentive regime described above. At each period end, management estimates the refundable tax offset available to the Company based on available information at the time.
Under the Australian Government’s research and development incentive program, a percentage of eligible research and development expenses incurred by the Company through its subsidiary in Australia are reimbursed. The percentage was
The research and development incentive receivable represents an amount due in connection with the above program. The Company recorded a research and development incentive receivable of $
During the nine months ended September 30, 2026, the Company received $
15
The following table shows the change in the research and development incentive receivable from January 1, 2025 to September 30, 2026 (in thousands):
| | | |
Balance at January 1, 2025 | | $ | |
Australian research and development incentives | |
| ( |
Foreign currency translation | |
| |
Balance at December 31, 2025 | | | |
Foreign currency translation | | | |
Cash received for eligible expenses | | | ( |
Reversal of previously recognized Australian research and development incentives | | | ( |
Balance at September 30, 2026 | | $ | — |
Foreign Currency Translation
The financial statements of the Company’s Australian subsidiary are measured using the local currency as the functional currency. The assets and liabilities of this subsidiary are translated into U.S. dollars at an exchange rate as of the consolidated balance sheet date. Equity is translated at historical exchange rates. Revenues and expenses are translated into U.S. dollars at average rates of exchange in effect during the period. The resulting cumulative translation adjustments have been recorded as a separate component of stockholders’ equity. Realized and unrealized foreign currency transaction gains and losses are included in the results of operations.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to credit risk consist principally of cash and cash equivalents. All cash and cash equivalents are held in U.S. or Australian financial institutions and money market funds. At times, the Company may maintain cash balances in excess of the federally insured amount of $250 per depositor, per insured bank, for each account ownership category. Although the Company currently believes that the financial institutions with whom it does business will be able to fulfill their commitments to the Company, there is no assurance that those institutions will be able to continue to do so. The Company has not experienced any credit losses associated with its balances in such accounts for the year ended December 31, 2025 or for the nine months ended September 30, 2026.
Restructuring Charges
On June 23, 2025, the Company’s Board of Directors approved a series of measures to conserve cash and reduce operating costs, including (i) the completion of the DeFianCe clinical trial and the wind-down of the Company’s research and development activities, including the Company’s sirexatamab and FL-501 development programs, and (ii) a reduction in force that impacted approximately
Deferred Costs
The Company capitalizes certain legal, professional, accounting and other third-party fees that are directly associated with in-process equity financings as deferred costs until such financings are consummated. After consummation of the equity financing, these costs are recorded in stockholders’ equity as a reduction of additional paid-in capital generated as a result of the offering.
The Company recorded deferred offering costs of $
16
Deposits
As of September 30, 2026 and December 31, 2025, there were $
Warrants
The Company will recognize on a prospective basis the value of the effect of the down round feature in the warrants to purchase shares of common stock that were issued in a private placement in March 2020 (the “March 2020 Coverage Warrants”) when it is triggered (i.e., when the exercise price is adjusted downward). This value is measured as the difference between (1) the financial instrument’s fair value (without the down round feature) using the pre-trigger exercise price and (2) the financial instrument’s fair value (with the down round feature) using the reduced exercise price. The value of the effect of the down round feature will be treated as a dividend and a reduction to income available to common stockholders in the basic earnings per share (“EPS”) calculation.
Fair Value of Financial Instruments
Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:
| ● | Level 1—Quoted prices in active markets for identical assets or liabilities. |
| ● | Level 2—Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. |
| ● | Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. |
A summary of the assets carried at fair value in accordance with the hierarchy defined above is as follows (in thousands):
| | Total | | Level 1 | | Level 2 | | Level 3 | ||||
September 30, 2026 | | | | | | | | | | | | |
Assets: | | | | | | | | | | | | |
Cash equivalents | | $ | | | $ | | | $ | — | | $ | — |
Digital assets receivable | | | | | | | | | — | | | — |
Total assets | | $ | | | $ | | | $ | — | | $ | — |
| | | | | | | | | | | | |
December 31, 2025 | | | | | | | | | | | | |
Assets: | | | | | | | | | | | | |
Cash equivalents | | $ | | | $ | | | $ | — | | $ | — |
Digital assets receivable | | | | | | | | | — | | | — |
Total assets | | $ | | | $ | | | $ | — | | $ | — |
Cash equivalents of $
17
The fair value of the embedded derivative associated with Digital assets receivable is measured using the ask (best sell price) as of 11:00 p.m. Eastern Standard Time on the last day of the reporting period for Zcash in active markets in which the Company transacts. As the Digital assets receivable are collectible on demand, its fair value is directly based on observable market prices for the underlying digital assets without adjustment for credit risk, duration, or other entity-specific assumptions. Accordingly, the embedded derivative is classified within Level 1 of the fair value hierarchy under ASC 820, Fair Value Measurement, as its fair value is determined using quoted prices for identical assets in active markets.
The carrying value of the research and development incentive receivable, accounts payable and accrued expenses approximate their fair value due to the short-term nature of these assets and liabilities.
Segment Information
The Company determines its operating segments in accordance with Accounting Standards Codification (“ASC”) 280, Segment Reporting. Operating segments are identified based on the manner in which the Company’s Chief Operating Decision Maker (“CODM”) evaluates financial information for purposes of allocating resources and assessing performance.
Effective during the three months ended September 30, 2026, the Company determined that it operates through
The Company’s Chief Executive Officer serves as the CODM and evaluates segment performance primarily based on operating income (loss). Additional information regarding the Company’s reportable segments is included in Note 16.
Net Income (Loss) per Share
Basic net income (loss) per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed using the weighted average number of common shares outstanding during the period and, if dilutive, the weighted average number of potential shares of common stock, including the assumed exercise of stock options and warrants.
Subsequent Events
The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that require additional disclosure. Subsequent events have been evaluated as required.
Recently Issued Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified date.
In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”), and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date (“ASU 2025-01”). ASU 2024-03 requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement. ASU 2024-03, as clarified by ASU 2025-01, will be effective for annual reporting periods beginning after December 15, 2026 on a prospective basis. Both early adoption and retrospective application are permitted. The Company is currently evaluating the impact that the adoption of these standards will have on its consolidated financial statements and disclosures.
3. Asset Purchase Agreement and Pre-Funded Warrant
During the three months ended September 30, 2026, the Company entered into an Asset Purchase Agreement (the “APA”) with Moria Mining, LLC, a Delaware limited liability company (“Moria” or the “Seller”), Winklevoss Treasury Investments, LLC, a
18
Delaware limited liability company and an affiliate of the Seller (“Winklevoss Capital”), and Cypherpunk Mining, a Delaware limited liability company and a wholly owned subsidiary of the Company (“Cypherpunk Mining”).
Pursuant to the APA, the Company agreed (i) to purchase and acquire certain assets and rights (collectively, the “Purchased Assets”), consisting solely of (a) Mining Equipment (as defined in the APA), (b) Hosting Agreements (as defined in the APA), and (c) Deposits (as defined in the APA), at an aggregate purchase price of $
The fair value of the consideration paid was used to measure the cost of the Mining Asset Acquisition under ASC 805-50-30-2. The Company’s ending share price on the date of the acquisition, August 17, 2026, was $
The exercise price of the August 2026 Pre-Funded Warrant is equal to $
The Seller is an affiliate of Winklevoss Capital, and Winklevoss Capital beneficially owns approximately
The purchase price allocation of assets acquired was as follows:
Mining equipment | | $ | |
Deposits | |
| |
Total value of assets acquired | | $ | |
4. Revenue
The Company participates in mining pools operated by third parties. As a participant in the mining pools, the Company provides a service to perform hash calculations for the mining pools, and the Company is entitled to non-cash consideration based on the pool operator’s payout model, which is Pay-Per-Share+ (“PPS+”). The pools pay block rewards and transaction fees, less mining pool fees. Under the PPS+ model, the Company is entitled to non-cash consideration even if a block is not successfully validated by the mining pool operators.
The contracts are terminable at any time by either party with no substantive termination penalty. The Company’s enforceable right to compensation begins when, and lasts for as long as, the Company provides computing power to the mining pool operator. The Company’s performance obligation extends over the contract term given the Company’s continuous provision of hashrate. This period of time corresponds with the period of service for which the mining pool operator determines compensation due to the Company. Given cancellation terms of the contract, and the Company’s customary business practice, the contract effectively provides the
19
Company with the option to renew for successive contract terms of 24 hours. The options to renew are not material rights because they are offered at the standalone selling price of computing power.
PPS+ Mining Pools
The Company participates in Pay-Per-Share Plus (“PPS+”) mining pools. Under the PPS+ model, participants receive consideration based on the computational power contributed to the mining pool. Consideration consists of (i) block rewards earned by the mining pool operator and (ii) transaction fees associated with blocks successfully mined by the pool, net of mining pool fees.
Unlike Full-Pay-Per-Share (“FPPS”) pools, where transaction fee rewards are determined based on estimated network transaction fees, PPS+ pools distribute transaction fees based on the participant’s proportionate share of actual transaction fees earned from specific blocks successfully mined by the pool during a daily settlement period in accordance with the mining pool operator’s specifications.
The Company’s consideration under PPS+ arrangements is non-cash and variable because it is dependent on factors including the Company’s contributed hashrate, network mining difficulty, block rewards, transaction fees, and mining pool fees. The Company estimates the variable consideration at contract inception and concludes that it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. Accordingly, the Company does not constrain the estimated variable consideration.
Revenue is recognized when the Company transfers control of its contracted service of providing hashrate to the mining pool operator, which occurs continuously throughout the contract period and is measured daily. The non-cash consideration received is measured at fair value at contract inception using the daily spot price of Zcash in the Company’s principal market.
The following table presents disaggregation of the Company’s mining revenues:
| | | | | | | | | | | | |
| | Three Months Ended September 30, | | Nine Months Ended September 30, | ||||||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
Revenues from contracts with customers: | | | | | | | | | | | | |
Mining pool participant - third party | | | | | | | | | | | | |
Zcash | | $ | | | $ | — | | $ | | | $ | — |
Total mining pool participant - third party | |
| | |
| — | |
| | |
| — |
Total mining revenues | | $ | | | $ | — | | $ | | | $ | — |
5. Digital Assets Receivable
The Company acquires ZEC through both open market purchases and, beginning in the three months ended September 30, 2026, from its digital asset mining operations. As of September 30, 2026, the Company held a total of
Digital assets receivable is initially recorded at the transaction price, and the embedded derivative is subsequently measured at the fair value of the underlying digital assets to be received. Changes in fair value of the embedded derivative are recognized as unrealized gains on the change in fair value of embedded derivative in the consolidated statement of operations. The carrying value of the host contract and the embedded derivative as of September 30, 2026 was $
The balance of digital assets receivable was $
20
6. Property and Equipment, Net
Property and equipment, net consists of the following:
| | September 30, | | December 31, | ||
| | 2026 | | 2025 | ||
| | | | | | |
Mining equipment | | $ | | | $ | — |
Computer office equipment | |
| | |
| |
Leasehold improvements | |
| | |
| |
Lab equipment | |
| | |
| |
Furnitures and fixtures | |
| | |
| |
| |
| | |
| |
Less: accumulated depreciation | |
| ( | |
| ( |
Property and equipment, net | | $ | | | $ | — |
Depreciation expense was $
7. Stock Subscription Receivable
In November 2025, the Company entered into a Controlled Equity OfferingSM Sales Agreement (the “Sales Agreement”) with Cantor Fitzgerald & Co. (“Cantor”), pursuant to which the Company may, from time to time, offer and sell shares of its common stock having an aggregate offering price of up to $
In connection with the Sales Agreement, the Company issued
8. Other Investment
ZODL Investment
During the nine months ended September 30, 2026, the Company announced an investment of $
21
As of September 30, 2026, the Company recorded the $
9. Accrued Expenses
Accrued expenses consists of the following:
| | | | | | |
| | September 30, | | December 31, | ||
| | 2026 | | 2025 | ||
Hosting expenses | | $ | | | $ | — |
Clinical trials | | | — | | | |
Professional fees | |
| | |
| |
Payroll and related expenses | |
| | |
| |
Severance | | | — | | | |
Accrued expenses | | $ | | | $ | |
10. Warrants
As of September 30, 2026, the number of shares of common stock issuable upon the exercise of outstanding warrants consisted of the following:
| | | | | | | |
September 30, 2026 | | | |||||
| | Number of Common | | | | | |
Description | | Shares Issuable | | Exercise Price | | Expiration Date | |
January 23, 2017 Warrants | | | | $ | | | Upon M&A Event |
March 2020 Coverage Warrants | | | | $ | | | January 2027 |
October 2025 Pre-funded Warrants | | | | $ | | | No Expiry |
October 2025 Common Warrants | | | | $ | | | October 2035 |
August 2026 Pre-funded Warrants | | | | $ | | | No Expiry |
| | | | | | | |
2019 Warrants
In connection with a public offering that the Company completed on February 5, 2019, the Company issued immediately exercisable warrants (the “2019 Warrants”) to investors. The 2019 Warrants had an exercise price of $
March 2020 Pre-funded Warrants
In March 2020, the Company’s stockholders approved the conversion of the Series A Preferred Stock into a pre-funded warrant to purchase shares of common stock at an exercise price of $
September 2021 Pre-funded Warrants
In September 2021, the Company completed a public offering, whereby the Company issued pre-funded warrants to purchase shares of its common stock (the “September 2021 Pre-funded Warrants”) to certain investors. During the nine months ended September 30, 2025,
22
January 2023 Common Stock Warrants
In January 2023, in connection with Leap’s acquisition of Flame, the warrants held by the Flame warrant holders became exercisable for
January 2023 Series X Preferred Stock Warrants
In January 2023, in connection with Leap’s acquisition of Flame, the warrants held by the Flame warrant holders also became exercisable for
April 2024 Pre-funded Warrants
In April 2024, the Company issued pre-funded warrants to purchase shares of common stock (the “April 2024 Pre-funded Warrants”) as part of a private placement. During the nine months ended September 30, 2025,
October 2025 Pre-funded Warrants
In October 2025, the Company completed a private placement, whereby it issued the October 2025 Pre-Funded Warrants (as defined below in Note 11) to purchase up to an aggregate of
During the three months ended September 30, 2026,
October 2025 Common Stock Warrants
In October 2025, the Company completed a private placement (the “October 2025 Private Placement”), whereby the Company issued the October 2025 Common Warrants to Investors (as defined below in Note 11) to purchase up to an aggregate of
Parcrest International (“Parcrest”) served as the Company’s placement agent in connection with the October 2025 Private Placement. The Company agreed to pay Parcrest $
August 2026 Pre-funded Warrants
In August 2026, the Company entered into an APA (see Note 3), whereby it issued the August 2026 Pre-Funded Warrants to WTI, to purchase up to an aggregate of
23
of certain stock dividends, stock splits, stock combinations, or similar events affecting the common stock. The August 2026 Pre-Funded Warrants qualify for equity classification.
11. Common Stock
Each share of common stock entitles the holder to
Private Placement – October 2025
Securities Purchase Agreement
On October 6, 2025, the Company entered into a Securities Purchase Agreement with Winklevoss Capital as Lead Investor (the “Lead Investor”) and the other investors named therein, for the private placement of (i)
Lead Investor Agreement
In connection with the Securities Purchase Agreement, the Company entered into a Lead Investor Agreement, dated October 6, 2025 (the “Lead Investor Agreement”) with Winklevoss Capital to secure its commitment as Lead Investor in the October 2025 Private Placement. WTI beneficially owns approximately
Issuance of Common Stock under Sales Agreement — November 2025
During the year ended December 31, 2025, the Company entered into a Sales Agreement with Cantor, pursuant to which the Company may offer and sell shares of its common stock, par value $
Subject to the terms and conditions of the Sales Agreement, Cantor will use its commercially reasonable efforts consistent with its normal trading and sales practices, applicable state and federal law, rules and regulations, and the rules of the Nasdaq Capital Market to sell the shares pursuant to the offering from time to time, based upon the Company’s instructions, including any price, time or size limits specified by the Company. The Company has provided Cantor with customary indemnification and contribution rights in favor of Cantor, and Cantor earns a commission of
The Company has no obligation to sell any of the shares and may at any time suspend offers under the Sales Agreement. The Company and Cantor may each terminate the Sales Agreement at any time upon
24
During the three months ended September 30, 2026, the Company issued
12. Equity Incentive Plans
Equity Incentive Plans
On January 20, 2017, the Company’s stockholders approved the 2016 Equity Incentive Plan (the “2016 Plan”). Beginning on January 1, 2018, the number of shares of common stock authorized for issuance pursuant to the 2016 Plan was increased each January 1 by an amount equal to
On June 16, 2022, the Company’s stockholders approved the 2022 Equity Incentive Plan (the “2022 Plan”), which provides for a total of
On December 15, 2025, the Company held a special meeting of stockholders (the “Special Meeting”). The Company’s stockholders voted to approve the adoption of the Company’s 2025 Equity Incentive Plan (the “2025 Plan”) at the Special Meeting, and the 2025 Plan became immediately effective upon such approval. The 2025 Plan, among other matters, provides for a total of
As of September 30, 2026, there were
A summary of stock option activity under the equity incentive plans is as follows:
| | | | Weighted | | Weighted | | | | |
| | | | Average |
| Average | | Aggregate | ||
| | | | Exercise Price |
| Remaining | | Intrinsic | ||
| | Options | | Per Share | | Life in Years | | Value | ||
Outstanding at December 31, 2025 |
| | | $ | |
| | $ | — | |
Granted | | | | $ | | | — | | | — |
Exercised | | ( | | $ | | | — | | | — |
Forfeited |
| ( | | $ | |
| — | | | — |
Outstanding at September 30, 2026 |
| | | $ | |
| | $ | | |
Options exercisable at September 30, 2026 |
| | | $ | |
| | $ | | |
Options vested and expected to vest at September 30, 2026 |
| | | $ | |
| | $ | | |
The assumptions that the Company used to determine the grant-date fair value of stock options granted to employees and directors during the nine months ended September 30, 2026 were as follows, presented on a weighted average basis:
| | Nine Months Ended | |
| | September 30, | |
| | 2026 | |
Expected volatility | | | % |
Weighted average risk-free interest rate | | | % |
Expected dividend yield | | | % |
Expected term (in years) | | |
25
Stock options generally vest over a three or
Restricted Stock Units (“RSUs”)
The following table presents RSU activity under the Company’s Equity Incentive Plans during the nine months ended September 30, 2026:
| | | | Weighted | |
| | | | Average Grant | |
| | Number of Shares | | Date Fair Value | |
Outstanding at December 31, 2025 |
| | | $ | |
Settled by the issuance of common stock | | ( | | $ | |
Granted | | | | $ | |
Outstanding at September 30, 2026 |
| | | $ | |
During the nine months ended September 30, 2026, the Company granted
During the nine months ended September 30, 2026,
The Company recognized stock-based compensation expense related to the issuance of stock option awards and RSUs to employees and non-employees in the condensed consolidated statements of operations during the three and nine months ended September 30, 2026 and 2025 as follows:
Stock Based Compensation Expense
| | | | | | | | | | | | |
| | Three Months Ended September 30, | | Nine Months Ended September 30, | ||||||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
Research and development |
| $ | — | | $ | | | $ | — | | $ | |
General and administrative |
| | | |
| | | | | |
| |
Restructuring charges | | | — | | | — | | | — | | | |
Total | | $ | | | $ | | | $ | | | $ | |
26
13. Net Income (Loss) Per Share
Basic and diluted net income (loss) per share for the three and nine months ended September 30, 2026 and 2025 was calculated as follows (in thousands except share and per share amounts).
| | Three Months Ended September 30, | | Nine Months Ended September 30, | ||||||||
| | 2026 | | 2025 | | 2026 | | 2025 | ||||
Numerator: |
| | | | | | | | | | | |
Net income (loss) attributable to common stockholders for basic and diluted loss per share | | $ | | | $ | ( | | $ | | | $ | ( |
| | | | | | | | | | | | |
Denominator: | |
| | |
| | |
| | |
| |
Weighted average number of common shares outstanding - basic | |
| | |
| | |
| | |
| |
Weighted average effect of potentially dilutive securities: | | | | | | | | | | | | |
Effect of potentially dilutive common stock warrants | | | | | | — | | | | | | — |
Effect of potentially dilutive restricted stock units | | | | | | — | | | | | | — |
Effect of potentially dilutive stock options | | | | | | — | | | | | | — |
Weighted average common shares outstanding — diluted | | | | | | | | | | | | |
| | | | | | | | | | | | |
Net income (loss) per share attributable to common stockholders: | | | | | | | | | | | | |
Basic | | $ | | | $ | ( | | $ | | | $ | ( |
Diluted | | $ | | | $ | ( | | $ | | | $ | ( |
Included within weighted average common shares outstanding for the three and nine months ended September 30, 2026 are
The Company’s potentially dilutive securities include RSUs, stock options and warrants. The following table includes the potential shares of common stock, presented based on amounts outstanding at each period end, that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
| | Three Months Ended September 30, | | Nine Months Ended September 30, | ||||
| | 2026 | | 2025 | | 2026 | | 2025 |
Options to purchase common stock |
| | | | | | | |
Warrants to purchase common stock | | | | | | | | |
Restricted stock units to purchase common stock |
| | | — | | | | — |
|
| | | | | | | |
14. Income Taxes
During the three and nine months ended September 30, 2026, the Company recorded an income tax expense of $
15. Commitments and Contingencies
Insurance Financing Agreement—During the nine months ended September 30, 2026, the Company entered into an insurance premium financing and security agreement with Aon Premium Finance, LLC. Under the agreement, the Company financed $
27
Next Generation Mining Machines Letter of Intent—In September 2026, the Company entered into a non-binding letter of intent with Bitmain Technologies Delaware Limited (“Bitmain”) for the purchase of Bitmain’s next generation Zcash mining machines with a total purchase commitment of up to $
Hosting Agreements—Cypherpunk Mining is party to hosting agreements with third-party facilities at which its mining equipment is installed, under which it pays fees based principally on the electricity consumed by its equipment. The agreements have initial terms expiring in mid-2027. Hosting deposits of $
License and Service Agreement—On January 3, 2011, the Company entered into a license agreement with Eli Lilly and Company (“Lilly”), a shareholder, to grant a license to the Company for certain intellectual property rights relating to pharmaceutically active compounds that may be useful in the treatment of bone healing, cancer and, potentially, other medical conditions. As defined in the license agreement, the Company would be required to pay royalties to Lilly based upon a percentage in the low single digits of net sales of developed products, if and when achieved. However, there can be no assurance that clinical or commercialization success of developed products will occur, and
Collaboration Agreement—On August 10, 2020, the Company entered into a collaboration agreement with Adimab, LLC (the “Adimab Agreement”), pursuant to which Adimab will conduct research programs to develop monoclonal antibodies to certain targets identified by the Company and provide it with an option to acquire exclusive rights to such antibodies. Upon payment of an option fee, on a product-by-product basis, Adimab will grant the Company a world-wide, exclusive license for, or assign ownership to the Company of, certain intellectual property rights and grant the Company a non-exclusive license with respect to the Adimab platform technology. As defined in the Adimab Agreement, after exercising an option and making the option payment, the Company would be required to pay Adimab milestones upon the completion of clinical development and regulatory milestones, along with a royalty in the low-single digits of net sales of each product, if and when achieved. However, there can be no assurance that clinical, or commercialization success will occur, and
Legal Proceedings—At each reporting date, the Company evaluates whether a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses as incurred the costs related to its legal proceedings. As of the date of this report, the Company is not currently a party to any material legal proceedings.
Indemnification Agreements—In the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with members of its Board of Directors that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date, the Company has not incurred any material costs as a result of such indemnifications. The Company is not aware of any claims under indemnification arrangements, and it has not accrued any liabilities related to such obligations in its condensed consolidated financial statements as of September 30, 2026 or December 31, 2025.
16. Segment Information
During the three months ended September 30, 2026, the Company determined that its operations are managed through
The Biotechnology segment is focused on the development of novel therapeutics. Activities within this segment include research and development, clinical advancement, intellectual property management, and business development activities associated with drug development.
28
The Privacy Technology segment is focused on digital privacy infrastructure and related technologies. Activities within this segment include digital asset mining operations, ownership and management of digital assets, privacy-focused technology initiatives, and related business activities.
The Company’s Chief Executive Officer serves as the Chief Operating Decision Maker (“CODM”) and regularly reviews operating results, cash expenditures, and other financial information for each segment to allocate resources and assess performance.
The accounting policies of the reportable segments are consistent with those described in Note 2, Significant Accounting Policies. Segment performance is evaluated based on operating income (loss). Corporate expenses, including certain executive, legal, finance, insurance, public company, and other administrative costs, are reported within Corporate and are not allocated to the operating segments when regularly reviewed by the CODM.
The following tables present selected financial information by reportable segment:
Condensed Consolidated Statement of Operations Information
| | | | | | | | | | | | |
Three Months Ended September 30, 2026 | | Privacy | | | | | | | | | | |
| | Technology | | Biotechnology | | Corporate | | Total | ||||
| | | | | | | | | | | | |
Mining revenue | | $ | | | $ | — | | $ | — | | $ | |
Total revenue | |
| | |
| | |
| | |
| |
| | | | | | | | | | | | |
Cost of revenue | |
| | |
| — | |
| — | |
| |
Research and development expenses | |
| — | |
| | |
| — | |
| |
General and administrative expenses | |
| | |
| — | |
| | |
| |
Depreciation and amortization | |
| | |
| — | |
| — | |
| |
Total operating costs and expenses | |
| | |
| | |
| | |
| |
| | | | | | | | | | | | |
Income (loss) from operations | | $ | | | $ | ( | | $ | ( | | $ | |
| | | | | | | | | | | | |
Nine Months Ended September 30, 2026 | | Privacy | | | | | | | | | | |
| | Technology | | Biotechnology | | Corporate | | Total | ||||
| | | | | | | | | | | | |
Mining revenue | | $ | | | $ | — | | $ | — | | $ | |
Total revenue | |
| | |
| | |
| | |
| |
| | | | | | | | | | | | |
Cost of revenue | |
| | |
| — | |
| — | |
| |
Research and development expenses | |
| — | |
| | |
| — | |
| |
General and administrative expenses | |
| | |
| — | |
| | |
| |
Depreciation and amortization | |
| | |
| — | |
| — | |
| |
Total operating costs and expenses | |
| | |
| | |
| | |
| |
| | | | | | | | | | | | |
Income (loss) from operations | | $ | | | $ | ( | | $ | ( | | $ | ( |
29
Assets by Segment
As of September 30, 2026 | | Privacy | | | | | | |
| | Technology | | Biotechnology | | Corporate | | Total |
| | | | | | | | |
Cash and cash equivalents |
| — |
| — |
| |
| |
Digital assets receivable |
| |
| — |
| — |
| |
Prepaid expenses and other current assets |
| — |
| — |
| |
| |
Property and equipment, net |
| |
| — |
| — |
| |
Right-of-use assets, net |
| — |
| — |
| |
| |
Deferred costs |
| — |
| — |
| |
| |
Deposits |
| |
| — |
| — |
| |
Other investment |
| |
| — |
| — |
| |
Total assets |
| |
| — |
| |
| |
17. Subsequent Events
Change in Fair Value of Embedded Derivative
During the period from October 1, 2026 until November 12, 2026, the price of ZEC has been volatile, ranging from high prices of above $
ZEC Purchases
During the period from October 1, 2026 until November 13, 2026, the Company purchased an additional
Exercise of Pre-Funded Warrants
On October 12, 2026, WTI exercised the October 2025 Pre-Funded Warrants to purchase
30
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand our results of operations and financial condition. This MD&A is provided as a supplement to, and should be read in conjunction with, our condensed consolidated financial statements and the accompanying notes thereto and other disclosures included in this Quarterly Report on Form 10-Q, including the disclosures under Part II, Item IA “Risk Factors,” and our audited condensed consolidated financial statements and the accompanying notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the Securities and Exchange Commission, or the SEC, on March 16, 2026 (the “Annual Report”). Our condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and, unless otherwise indicated, amounts are presented in U.S. dollars. Unless otherwise indicated, dollar amounts in the tables in this MD&A are presented in thousands, except for per-share amounts, the price of ZEC, quantities of ZEC, hashrate and the per-unit mining metrics described under “Key Operating Metrics.”
In this Quarterly Report, “Zcash” refers to the Zcash protocol and network, “ZEC” refers to the digital asset native to that network, “Cypherpunk Mining” refers to our wholly owned subsidiary Cypherpunk Mining LLC, and “Leap” refers to our wholly owned subsidiary Leap Therapeutics, Inc. Hashrate is stated in gigasolutions per second (“GSol/s”) or kilosolutions per second (“kSol/s”), the units in which the computational power applied to the Zcash network’s Equihash proof-of-work algorithm is conventionally measured.
Company Overview
We are a privacy technology company. Our mission is to advance technologies that guarantee privacy for all humans on the internet. Our initial focus is to participate in the Zcash ecosystem, which we believe represents the most mature and compliant implementation of private digital money. We pursue our Zcash focus through three strategic pillars: (a) treasury, (b) mining, and (c) investment. ZEC is the anchor of our digital asset treasury strategy. We mine ZEC through Cypherpunk Mining, which operates a fleet of Zcash mining machines at third-party hosting facilities in the United States (“U.S.”). We invest in privacy-enhancing technologies and the organizations that build them, starting with the Zcash Open Development Lab (“ZODL”).
Prior to October 2025, we devoted substantially all of our resources to the development of biomarker-targeted antibody therapies for patients with cancer. In October 2025, following a $58.88 million private placement led by Winklevoss Treasury Investments, LLC (“Winklevoss Capital”), we initiated a strategy to deploy the portion of our capital that is not required for working capital to accumulate digital assets, focused on Zcash. On November 12, 2025, we changed our name from “Leap Therapeutics, Inc.” to “Cypherpunk Technologies Inc.” and our trading symbol from “LPTX” to “CYPH.” Our biotechnology research and development operations continue to be conducted through our Leap Therapeutics, Inc. subsidiary. We do not have any therapeutic products approved for sale and have not generated any revenue from therapeutic product sales. We have funded our operations primarily through the proceeds of sales of common stock, pre-funded warrants to purchase common stock, and preferred stock. Since August 18, 2026, we have generated revenue from Zcash mining, which we receive in ZEC.
The Zcash Network
Zcash is a decentralized, open-source blockchain network that was launched in October 2016 using a modified version of the Bitcoin codebase. ZEC has a fixed maximum supply of 21 million coins, of which approximately 17.0 million were in circulation at September 30, 2026. New ZEC is issued through block subsidies paid to miners who validate transactions by performing the Equihash proof-of-work algorithm, with a portion allocated under the Zcash network’s consensus rules to development funding. Until the activation of the Zcash network’s upgrade known as NU7 on November 5, 2026, blocks were targeted every 75 seconds and the block subsidy was 1.5625 ZEC per block, of which 80% (1.25 ZEC per block) was paid to miners. NU7 reduced the target block interval to 25 seconds and reduced the block subsidy to one-third of its prior level, to 0.52083333 ZEC per block, of which approximately 80% (0.41666668 ZEC per block) is paid to miners and the remaining 20% allocated to development funding. Approximately three times as many blocks are now produced each day but the total amount of ZEC issued to miners each day, approximately 1,440 ZEC, is unchanged by NU7. All references in this Quarterly Report to our mining results for the quarter ended September 30, 2026 relate to the period before NU7. The share of block rewards that our fleet earns is approximately proportional to our hashrate relative to total network hashrate, so that the amount of ZEC we mine in any period depends on the number of our machines online, their uptime, and the hashrate contributed by all other miners, none of which, other than our own uptime, we control.
31
A core feature of the Zcash Network is optional privacy. The protocol supports both transparent transactions and “shielded” transactions in which the sender, recipient, and amount are encrypted using zero-knowledge proofs. As of September 30, 2026, approximately 30% of all ZEC was held in shielded pools. The Zcash protocol is developed by several independent organizations and changes through network upgrades, which increasingly are informed by advisory votes of ZEC holders. Developments during and after the quarter include the “Ironwood” upgrade activated on July 28, 2026 and the coinholder votes in September 2026 in favor of the 25-second block interval and retention of the existing halving schedule.
Our Zcash Treasury
Our investment thesis for ZEC rests on two premises. First, Zcash is built on the same sound monetary principles as Bitcoin. There is a fixed supply of 21 million coins, open-source development, and decentralized consensus, but Zcash adds privacy-preserving transaction capabilities through zero-knowledge cryptography. We view Zcash as private digital money and a private store of value. Second, we believe that the market has not yet priced in the growing structural demand for financial privacy as data collection and surveillance capabilities expand. As of September 30, 2026, we held a total of 332,361.67 ZEC, of which 323,394.38 ZEC were purchased at an average purchase price of $341.83 per ZEC and 8,967.29 ZEC were earned through our mining operations, representing approximately 1.96% of the circulating supply of ZEC as of September 30, 2026. During the three and nine months ended September 30, 2026, we retained all of the ZEC we mined. Our current stated objective is to accumulate holdings over time representing at least 5% of the circulating supply of ZEC.
Our purchased and mined ZEC is held for us by Gemini Space Station, LLC and its subsidiaries (collectively, “Gemini”), an affiliate of Winklevoss Capital, our largest stockholder, as a third-party custodian.
Our Zcash Mining Operations
On August 17, 2026, in connection with an Asset Purchase Agreement (the “APA”), Cypherpunk Mining acquired from Moria Mining, LLC (“Moria”), an affiliate of Winklevoss Capital, Bitmain Antminer Z15 Pro Zcash mining machines, the colocation and hosting agreements under which the machines are installed and operated at three third-party hosting facilities and the related hosting deposits, and certain other assets, properties and rights, at an aggregate purchase price of $33.33 million (the “Mining Asset Acquisition”). The aggregate purchase price for the assets was paid in the form of a pre-funded warrant (the “Mining Warrant”) that was issued to Winklevoss Capital to purchase 43,290,042 shares (the “Warrant Shares”) of our common stock, par value $0.001 per share (“common stock”), at an exercise price of $0.001 per share. The number of Warrant Shares was determined by dividing the purchase price by $0.77 per share, the greater of the five day average Nasdaq closing price of our common stock and a price based on the net asset value of our ZEC holdings per share. For accounting purposes, the consideration was measured based on a price of $0.705 per share, which was the closing price on August 17, 2026, or $30.8 million, and was allocated to the Zcash mining machines and the hosting deposits. Because the Mining Asset Acquisition involved a related party, the transaction was approved by the Nominating and Corporate Governance Committee of our Board of Directors and the non-interested members of our Board of Directors under our Related Person Transaction Policy.
Our mining fleet launched on August 18, 2026 as the largest Zcash mining operation in the world at that time. The machines are installed at hosting facilities that are operated by three unaffiliated hosting providers. Under our hosting agreements, the hosting provider procures electricity and provides rack space, cooling, network connectivity, physical security, and on-site technicians who install, monitor, maintain, and repair our machines, in exchange for fees based principally on the electricity consumed by our machines. Our fleet has a deployed hashrate of approximately 4.2 GSol/s. At the closing of the Mining Asset Acquisition our fleet represented approximately 18% of total Zcash network hashrate, and at September 30, 2026 approximately 15%, reflecting the growth of the network during the quarter. We direct our hashrate to third-party mining pools under a payout method under which we receive ZEC daily in proportion to the hash calculations we contribute, net of the pool operator’s fee. Our mining business is led by Kevin Zhang, Head of Mining, who joined us in August 2026.
We currently intend to retain the ZEC we mine as part of our treasury and to fund our hosting and other mining costs, which are payable in U.S. dollars, from cash on hand and the proceeds of equity or debt financings, including sales under our at-the-market program.
To expand our mining fleet, in September 2026, Cypherpunk Mining entered into a letter of intent with Bitmain Technologies Delaware Limited (“Bitmain”) for the purchase of Bitmain’s next-generation Zcash mining machines with a total purchase commitment of up to $30.0 million, of which $6.0 million was paid as a refundable deposit, with delivery expected in mid-2027. The letter of intent does not obligate us to purchase the machines unless we enter into a definitive purchase agreement. Completion of this
32
transaction would expand our mining fleet in order to continue to maintain a sizeable percentage of the overall Zcash network hashrate as that hashrate increases over the next year.
Privacy Technology Investments
In March 2026, we invested $5.0 million in Znewco, Inc., doing business as Zcash Open Development Lab (“ZODL”), through a simple agreement for future equity (“SAFE”), as part of a financing of more than $25.0 million that also included a16z, Winklevoss Capital, Coinbase, Paradigm, and individual investors. ZODL, which was formed by the former Electric Coin Company team, develops the Zodl wallet (formerly Zashi), and contributes to Zcash protocol development. We intend to, over time, assemble a portfolio of complementary privacy technology investments and to build privacy enhancing software products.
Leap Therapeutics
Leap is a biopharmaceutical company developing novel biomarker-targeted antibody therapies for patients with cancer. Our clinical-stage program is sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1 (“DKK1”), for the treatment of patients with DKK1-high metastatic colorectal cancer (“CRC”) whose disease has progressed following one prior line of therapy. Following publication of the randomized Phase 2 DeFianCe study in Clinical Cancer Research, receipt of Fast Track designation in May 2026, and alignment with the FDA on the design of a registrational Phase 3 trial in a DKK1-high 2L CRC population, we initiated a strategic process to identify the best path forward for sirexatamab and to secure the resources required to advance the program into Phase 3 development. The process may include financing the program as an independent entity or a strategic transaction with a pharmaceutical or biotechnology company, including a partnership, license, collaboration, sale or other business combination. There can be no assurance that the process will result in any transaction or financing, and we have not set a timetable for its conclusion. We also have a preclinical antibody program, FL-501, with the potential to treat patients with cachexia.
Corporate Information and Employees
We were incorporated in Delaware on January 3, 2011. As of September 30, 2026, we had 7 full-time employees. Our principal executive offices are located in Cambridge, MA.
Key Operating Metrics
Beginning with the quarter ended September 30, 2026, we use the following operating metrics to evaluate our Zcash mining operations and our ZEC treasury: ZEC mined; average ZEC mined per operating day; average price of ZEC mined; deployed hashrate; fleet uptime; our share of total Zcash network hashrate; average hashprice; hosting cost per ZEC mined; the cost to mine one ZEC; and ZEC held. The mining metrics below cover the period from August 18, 2026, when our fleet began mining for our account, through September 30, 2026, a period of approximately 6 weeks, and are not indicative of a full quarter of operations. There are no comparable metrics for prior periods. None of these metrics is a measure of financial performance under GAAP. They are operating statistics that management uses to assess production, operating efficiency and the economics of mining, and they should be read together with our condensed consolidated financial statements.
33
Zcash Mining Operating Metrics
| | | | |
| | Period from August 18, 2026 |
| |
| | (commencement of mining) through |
| |
| | September 30, 2026 |
| |
ZEC mined (1) |
| | 8,967.29 | |
Average ZEC mined per operating day (2) |
| | 203.80 | |
Mining revenue (in thousands) (3) | | $ | 9,913 | |
Average fair value of ZEC mined (3) | | $ | 1,105.46 | |
Deployed hashrate at period end (GSol/s) (4) | |
| 4.2 | |
Fleet uptime (5) | |
| 95 | % |
Total Zcash network hashrate — average for the period (GSol/s) (6) | |
| 27.1 | |
Total Zcash network hashrate — at period end (GSol/s) (6) | |
| 28.7 | |
Share of network hashrate — average for the period (6) | |
| 14.7 | % |
Share of network hashrate — at period end (6) | |
| 14.6 | % |
Hosting costs (in thousands) (7) | | $ | 936 | |
Hosting cost per ZEC mined (7) | | $ | 104.33 | |
| (1) | ZEC mined represents the ZEC credited to us by our mining pools for the hash calculation services we provided during the period, net of the pool operator’s fee, and corresponds to the quantity of ZEC recognized as mining revenue. |
| (2) | Average ZEC mined per operating day is ZEC mined divided by the number of days in the period during which our fleet was mining for our account (44 days). |
| (3) | Average fair value of ZEC mined is mining revenue divided by ZEC mined, and reflects the fair value of ZEC at which mining revenue was recognized. |
| (4) | Deployed hashrate at period end is the total hashrate that our installed machines could generate if all were operating at 100% of the manufacturer’s specification. It is an indicator of capacity, not of production. Machines may be offline for maintenance, repair, curtailment, or power or network events. Our production depends on total network hashrate. |
| (5) | Fleet uptime is average operating hashrate expressed as a percentage of deployed hashrate during the period. |
| (6) | Total Zcash network hashrate is derived from publicly available network difficulty data. Our share of network hashrate is our average operating hashrate (or deployed hashrate, at period end) divided by total network hashrate. Because the amount of ZEC issued to miners each day is fixed by the Zcash protocol, our expected ZEC production is approximately proportional to our share of network hashrate. |
| (7) | Hosting costs are the fees charged by our hosting providers, which are based principally on the electricity consumed by our machines, maintenance and support, and are included in cost of mining revenue. Hosting cost per ZEC mined is hosting costs divided by ZEC mined. Hosting costs exclude depreciation, insurance, repairs, and personnel costs. |
Cost to Mine One ZEC
| | | | |
| | Period from August 18, 2026 |
| |
(in thousands, except ZEC quantities and per-ZEC amounts) | | through September 30, 2026 |
| |
Hosting costs (power and hosting fees) (1) | | $ | 936 | |
| | | | |
Cost of mining revenue, excluding depreciation of mining equipment | | $ | 936 | |
Depreciation of mining equipment (2) | | $ | 1,194 | |
Cost of mining revenue, including depreciation of mining equipment | | $ | 2,130 | |
ZEC mined | |
| 8,967.29 | |
Production value of one ZEC mined (3) | | $ | 1,105.46 | |
Cost to mine one ZEC, excluding depreciation of mining equipment | | $ | 104.33 | |
as a percentage of production value of one ZEC mined | |
| 9.44 | % |
Cost to mine one ZEC, including depreciation of mining equipment | | $ | 237.46 | |
as a percentage of production value of one ZEC mined | |
| 21.48 | % |
| (1) | Hosting costs are described in note (8) to the preceding table. Our hosting agreements provide for fees of $0.067-$0.072 per kWh consumed. |
| (2) | We capitalize the cost of our mining machines in property and equipment and depreciate them on a straight-line basis over an estimated useful life of 3 years. We do not consider depreciation in deciding whether it is economic to operate our machines because it is a non-cash expense that is not avoided by curtailing operations. |
34
| (3) | Production value of one ZEC mined is mining revenue divided by ZEC mined (the same figure as average price of ZEC mined above). |
ZEC Holdings
The following table reconciles the change in our ZEC holdings during the three months ended September 30, 2026 to the amounts recorded on our condensed consolidated balance sheet:
(in thousands, except ZEC quantities) | | ZEC | | Carrying value | |
Balance at June 30, 2026 |
| 323,394.38 | | $ | 129,387 |
ZEC purchased |
| — | |
| — |
ZEC earned through mining, at fair value when earned (1) |
| 8,967.29 | | $ | 9,913 |
ZEC sold or otherwise disposed of |
| — | |
| — |
Change in fair value of embedded derivative (2) |
| — | | $ | 330,846 |
Balance at September 30, 2026 |
| 332,361.67 | | $ | 470,146 |
| (1) | Measured at the fair value of ZEC at which mining revenue was recognized. |
| (2) | Remeasurement of the embedded derivative in our digital assets receivable to the fair value of the underlying ZEC at September 30, 2026 of $1,414.56 per ZEC. |
Zcash Market and Network Conditions
Price of ZEC
The price of ZEC increased from $400.09 per ZEC at June 30, 2026 to $1,414.56 per ZEC at September 30, 2026, and during the quarter ranged from a low of approximately $390 in early July to a high of approximately $1,690 in late September 2026, the highest level since 2016. The increase followed the activation of the Ironwood upgrade, the listing of ZEC exchange-traded products in the U.S. and Europe, and the coinholder votes described below. From October 1, 2026 through November 10, 2026, the price of ZEC has ranged between approximately $1,055 and $1,445. Because the embedded derivative in our digital assets receivable is remeasured to the fair value of the underlying ZEC at each balance sheet date, and because mining revenue is measured at the fair value of ZEC when it is earned, the price of ZEC is the principal driver of our reported results and of the volatility of those results from period to period.
Network Hashrate and Difficulty
Total Zcash network hashrate increased from approximately 23 GSol/s at August 18, 2026 to approximately 32 GSol/s at November 13, 2026, and network difficulty, which adjusts automatically to maintain the target block interval, increased correspondingly. We attribute the increase to the deployment of additional machines by other miners in response to the increase in the price of ZEC. Because the amount of ZEC issued to miners each day is fixed by the Zcash protocol (approximately 1,440 ZEC per day), growth in network hashrate reduces the ZEC earned per unit of hashrate. Our share of network hashrate declined from approximately 18% at the commencement of mining to approximately 13.1% at November 13, 2026, while our fleet operated at approximately 95% uptime. We expect network hashrate to continue to increase as additional and more efficient machines are delivered. Unless we add hashrate at least as fast as the network grows, the ZEC we mine in future periods will decline.
Block Subsidy, Transaction Fees, and Protocol Upgrades
Between August 25 and September 14, 2026, holders of ZEC in the Ironwood shielded pool participated in an advisory poll on the content of the next network upgrade, NU7, and voted overwhelmingly in favor of reducing the target block interval from 75 seconds to 25 seconds, retaining the existing halving schedule, and deferring until 2031 the reissuance to miners of transaction fees that would be removed from circulation under the proposed Network Sustainability Mechanism. NU7 was activated on the Zcash mainnet on November 5, 2026. NU7 reduced the target block interval from 75 seconds to 25 seconds and reduced the block subsidy to one-third of its prior level, from 1.5625 ZEC to 0.52083333 ZEC per block, of which approximately 80% (0.41666668 ZEC per block) is paid to miners and the remaining 20% is allocated under the protocol’s consensus rules to development funding. The amount of ZEC issued to miners each day, approximately 1,440 ZEC, is substantially unchanged, and the next halving remains expected in approximately November 2028.
35
Financial Overview
Mining Revenue
We generate mining revenue by providing hash calculation services to the operator of a mining pool, which we consider our customer under Accounting Standards Codification 606, Revenue from Contracts with Customers (“ASC 606”). Our arrangement with a pool operator is terminable at any time and renews continuously in periods of less than a day. Under the pool’s payout method, we are entitled to receive ZEC based on the hash calculations we contribute relative to the network as a whole, calculated by reference to the expected block subsidy and transaction fees for the period, net of the pool operator’s fee, whether or not the pool successfully validates a block. The consideration we receive is noncash consideration in the form of ZEC, which we measure at the fair value of ZEC using the quoted price in our principal market of Zcash. Changes in the fair value of ZEC after it is earned are not included in mining revenue. Mining revenue does not generate cash. It increases our holdings of ZEC, and the ZEC we earn is subsequently remeasured as described under “Change in Fair Value of Embedded Derivative and Digital Assets” below. We commenced mining on August 18, 2026, and we had no mining revenue in any prior period.
Cost of Mining Revenue (exclusive of depreciation and amortization)
Cost of mining revenue consists of the fees we pay our hosting providers under our hosting agreements, which are based principally on the electricity consumed by our machines, and include maintenance and support. Mining pool fees are deducted from the ZEC we receive and are reflected as a reduction of mining revenue rather than as a cost. We do not currently purchase electricity directly. Depreciation of our mining machines is presented separately.
Depreciation of Mining Equipment
We recorded the mining machines acquired in the Mining Asset Acquisition at their allocated cost of $30.0 million and depreciate them on a straight-line basis over an estimated useful life of three (3) years, which reflects our assessment of the period over which Equihash mining machines of this generation are expected to remain economic to operate as network hashrate and the efficiency of newer machines increase. We review our mining machines for impairment whenever events or changes in circumstances, including a sustained decline in the price of ZEC, an increase in network difficulty, the introduction of more efficient machines or a change to the Zcash protocol, indicate that their carrying amount may not be recoverable.
Research and Development Expenses
Our research and development activities have included conducting nonclinical studies and clinical trials, manufacturing development efforts and activities related to regulatory filings for our product candidates, primarily sirexatamab. We recognize research and development expenses as they are incurred. Our research and development expenses during the nine months ended September 30, 2026 consisted primarily of costs related to compliance with regulatory requirements and preparation for the Phase 3 program for sirexatamab. The successful development of our clinical product candidates is highly uncertain, and we cannot reasonably estimate the nature, timing, or costs of the efforts that will be necessary to complete the development of any of our product candidates or the period, if any, in which material net cash inflows from these product candidates may commence.
General and Administrative Expenses
General and administrative expenses consist primarily of salaries and related costs, including stock-based compensation, for personnel in executive, finance, and administrative functions, direct and allocated facility-related costs, and professional fees for legal, patent, consulting, accounting, and audit services. We anticipate that our general and administrative expenses will increase as we add personnel and advisers for our mining operations; incur transaction, audit, accounting, tax, and legal costs associated with digital assets, mining, and the Mining Asset Acquisition; and bear the director and officer insurance, compliance, investor relations, and other costs of a public company with a digital asset treasury and mining strategy.
Interest income and Interest Expense
Interest income consists primarily of interest income earned on cash and cash equivalents. Interest expense consists of interest on financed insurance premiums.
36
Change in Fair Value of Embedded Derivative and Digital Assets
Our ZEC held at Gemini is recorded as a digital assets receivable, a hybrid instrument consisting of a host receivable and an embedded derivative. The embedded derivative is remeasured at each balance sheet date based on the fair value of the underlying ZEC, and the change is recognized as an unrealized gain or loss on the change in fair value of the embedded derivative. These amounts are non-cash and fluctuate with the price of ZEC.
Income Taxes
Our provision for or benefit from income taxes consists principally of deferred income taxes on unrealized gains and losses on the embedded derivative and on ZEC earned through mining, net of the benefit of our net operating loss carryforwards to the extent they are available, which are subject to limitation under Section 382 of the Internal Revenue Code. Mining revenue is treated as ordinary income for U.S. federal income tax purposes at their fair market value when received.
Research and Development Incentive Income and Foreign Currency
Research and development incentive income includes payments under the Australian government’s research and development incentive program with respect to eligible expenses of our Australian subsidiary. We did not record any research and development incentive income in 2026, and the program is no longer material to our results. Foreign currency gains and losses arise from the revaluation of transactions of our Australian subsidiary and have been immaterial.
Critical Accounting Policies and Estimates
Our condensed consolidated financial statements are prepared in accordance with GAAP. The preparation of our financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, costs, and expenses, and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.
Our critical accounting policies are described under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Significant Judgments and Estimates” in our Annual Report on Form 10-K filed on March 16, 2026 and in the notes to the condensed consolidated financial statements appearing elsewhere in this Quarterly Report. Our critical accounting policies for research and development expenses and stock-based compensation have not changed since the Annual Report. As a result of the commencement of our mining operations, we believe that the following accounting policies, which are new or have been updated since the Annual Report, also involve significant judgment and complexity.
Digital Assets Receivable
We hold ZEC with Gemini, a third-party custodian. The contractual arrangement represents our enforceable contractual right to receive digital assets from the custodian on demand and is accounted for as a hybrid instrument under ASC 815, Derivatives and Hedging. The host contract is a non-interest bearing receivable collectible on demand, recorded at the transaction price, which is the fair value of the digital assets at the time of acquisition or, for ZEC earned through mining, the fair value at which mining revenue was recognized. The embedded derivative is bifurcated because the exposure to changes in the fair value of the underlying digital assets is not clearly and closely related to the host receivable, and is measured at fair value at each reporting date using observable prices in our principal market (Level 1), with changes recorded as an unrealized gain or loss on change in fair value of embedded derivative. We exercise judgment in determining our principal market, the fair value hierarchy, the bifurcation of the embedded derivative and the point at which control of mined ZEC transfers to the custodian. There is diversity in industry practice regarding the measurement and recognition of digital assets.
Mining Revenue
We recognize mining revenue under ASC 606 for hash calculation services provided to a mining pool operator, which we have concluded is our customer. Significant judgments include the identification of the contract and its duration (a continuously renewing contract of less than one day), the determination that the ZEC we receive is noncash consideration that is measured at fair
37
value at contract inception and is not subsequently remeasured through revenue, and the treatment of pool operator fees as a reduction of consideration. We measure the fair value of ZEC received using the quoted price in our principal market at the time of the deposit of ZEC each day.
Asset Purchase Agreement and Mining Equipment
The APA was treated as an acquisition of assets for accounting purposes rather than a business combination because substantially all of the fair value of the gross assets acquired is concentrated in a group of similar identifiable assets (the mining machines). The Mining Warrant issued as consideration in the Mining Asset Acquisition was measured at its fair value on the closing date of the transaction, and the cost of the acquisition was allocated to the mining machines and the hosting deposits on a relative fair value basis. Because Moria is a related party, we also evaluated whether the purchase price exceeded the fair value of the assets acquired and concluded that it did not, based on the market prices of Z15 Pro machines at the time of acquisition and the terms of the hosting agreements. We depreciate the machines over an estimated useful life of three (3) years and evaluate them for impairment when indicators are present. The principal inputs to the useful-life and impairment analyses are the price of ZEC, total network hashrate, the efficiency of our machines relative to machines available in the market, and anticipated changes to the Zcash protocol.
Results of Operations
Comparison of the Three Months Ended September 30, 2026 and 2025
The following table summarizes our results of operations for the three months ended September 30, 2026 and 2025:
| | Three Months Ended September 30, | | | | ||||
| | 2026 | | 2025 | | Change | |||
| | (in thousands) | | | | ||||
Mining revenue | | $ | 9,913 | | $ | — | | $ | 9,913 |
Operating costs and expenses: | | | | | | | | | |
Cost of revenue (excluding depreciation and amortization) | |
| 936 | |
| — | |
| 936 |
Research and development | | | 233 | | | 1,247 | | | (1,014) |
General and administrative | |
| 4,944 | |
| 1,919 | |
| 3,025 |
Depreciation and amortization | |
| 1,194 | |
| — | |
| 1,194 |
Total operating cost and expenses | | | 7,307 | | | 3,166 | | | 4,141 |
Income (loss) from operations | | | 2,606 | | | (3,166) | | | 5,772 |
Interest income | |
| 59 | |
| 123 | |
| (64) |
Interest expense | |
| (2) | |
| (10) | |
| 8 |
Australian research and development incentives | |
| — | |
| (56) | |
| 56 |
Change in fair value of embedded derivative | | | 330,846 | | | — | | | 330,846 |
Foreign currency gain | |
| — | |
| 8 | |
| (8) |
Income (loss) before income taxes | | | 333,509 | | | (3,101) | | | 336,610 |
Provision for income taxes | | | (27,504) | | | (202) | | | (27,302) |
Net income (loss) attributable to common stockholders | | $ | 306,005 | | $ | (3,303) | | $ | 309,308 |
Mining Revenue
Mining revenue was $9.9 million for the three months ended September 30, 2026, our first period of mining operations, and reflects 8,967.29 ZEC earned at an average fair value of $1,105.46 per ZEC. We had no revenue in the three months ended September 30, 2025. Our production during the period was affected by the increase in total network hashrate, which reduced our share of network hashrate from approximately 18% at the commencement of mining to approximately 15% at September 30, 2026. Mining revenue is a non-cash item, as we received ZEC, not cash.
Cost of Revenue (excluding depreciation and amortization)
Cost of revenue was $0.9 million for the three months ended September 30, 2026 and consisted of hosting costs, including electricity pass-through charges for 13,714 MWh consumed. We did not have any cost of revenue in the three months ended September 30, 2025.
38
Research and Development Expenses
| | | | | | | | | |
| | Three Months Ended September 30, | | | | ||||
| | | | | | | | Increase | |
| | 2026 | | 2025 | | (Decrease) | |||
|
| (in thousands) | | | | ||||
Direct research and development by program: |
| | |
| | |
| | |
DKN-01 program | | $ | 233 | | $ | 1,184 | | $ | (951) |
FL-501 program | | | — | | | 63 | | | (63) |
Total research and development expenses | | $ | 233 | | $ | 1,247 | | $ | (1,014) |
Research and development expenses were $0.2 million for the three months ended September 30, 2026, compared to $1.2 million for the three months ended September 30, 2025. The decrease of $1.0 million in research and development expenses during the three months ended September 30, 2026 as compared to the same period in 2025, was primarily due to a decrease of $0.7 million in clinical trial and manufacturing costs, due to the completion of our clinical trials. In connection with the Company’s reduction in force in 2025, there was also a decrease of $0.3 million in payroll and other related expenses due to a decrease in headcount of our R&D full-time employees.
General and Administrative Expenses
General and administrative expenses were $4.9 million for the three months ended September 30, 2026 compared to $1.9 million for the three months ended September 30, 2025. The increase of $3.0 million in general and administrative expenses during the three months ended September 30, 2026 as compared to the same period in 2025, was primarily due to a $2.2 million increase in stock based compensation expense due to restricted stock units (“RSUs”) granted to general and administrative employees and directors during the three months ended December 31, 2025 and during the three months ended September 30, 2026. There was also an increase of $0.4 million in professional fees due to increased audit and financial consulting fees associated with digital assets and increased legal fees in connection with the Asset Purchase Agreement. Additionally, there was an increase in insurance costs of $0.4 million during the three months ended September 30, 2026 as compared to the same period in 2025.
Depreciation and amortization
Depreciation expense related to our mining equipment was $1.2 million for the three months ended September 30, 2026, representing 44 days of depreciation of the mining machines that were acquired in the Mining Asset Acquisition on a straight-line basis over an estimated useful life of three (3) years.
Interest Income
We recorded interest income of $0.1 million during the three months ended September 30, 2026 and 2025, respectively.
Australian Research and Development Incentives
We record R&D incentive income based upon the applicable percentage of eligible research and development activities under the R&D Incentive Program, which expenses included the cost of manufacturing clinical trial material. During the three months ended September 30, 2025, we reversed ($0.1) million of previously recognized research and development incentive income. We did not record any Australian research and development incentives during the three months ended September 30, 2026.
The R&D incentive receivable has been recorded as “Research and development incentive receivable” in the condensed consolidated balance sheets.
Unrealized Gain on Change in Fair Value of Embedded Derivative
During the three months ended September 30, 2026, we recorded an unrealized gain of $330.8 million on the change in fair value of embedded derivative reflecting the increase in the price of ZEC from $400.09 per ZEC at June 30, 2026 to $1,414.56 per ZEC at September 30, 2026. We did not hold ZEC during the three months ended September 30, 2025.
39
Income Taxes
We recorded a provision for income taxes of $27.5 million for the three months ended September 30, 2026, compared to $0.2 million for the three months ended September 30, 2025. The provision for the 2026 period consists principally of deferred income tax expense on the unrealized gain on the embedded derivative, partially offset by the benefit of net operating loss carryforwards.
Net Income (Loss)
As a result of the foregoing, we recorded net income of $306.0 million, or $1.44 per basic share and $1.13 per diluted share, for the three months ended September 30, 2026, compared to a net loss of $3.3 million, or ($0.08) per basic and diluted share, for the three months ended September 30, 2025. Our net income for the 2026 period was primarily driven by the non-cash unrealized gain on the embedded derivative. Diluted weighted average shares for the 2026 period include 101,007,343 shares issuable upon exercise of pre-funded warrants and 59,492,330 shares attributable to common warrants, RSUs and other dilutive securities under the treasury stock method.
Foreign Currency Gain
During the three months ended September 30, 2026 and 2025, we recorded an immaterial amount of foreign currency transaction gains. Foreign currency transaction gains are due to changes in the Australian dollar exchange rate related to activities of the Australian entity.
Comparison of the Nine Months Ended September 30, 2026 and 2025
The following table summarizes our results of operations for the nine months ended September 30, 2026 and 2025:
| | Nine Months Ended September 30, | | | | ||||
| | 2026 | | 2025 | | Change | |||
| | (in thousands) | | | | ||||
Mining revenue | | $ | 9,913 | | $ | — | | $ | 9,913 |
Operating costs and expenses: | | | | | | | | | |
Cost of revenue (excluding depreciation and amortization) | |
| 936 | |
| — | |
| 936 |
Research and development | |
| 591 | |
| 24,695 | |
| (24,104) |
General and administrative | |
| 14,092 | |
| 6,742 | |
| 7,350 |
Depreciation and amortization | |
| 1,194 | |
| — | |
| 1,194 |
Restructuring charges | |
| — | |
| 4,527 | |
| (4,527) |
Total operating cost and expenses | |
| 16,813 | |
| 35,964 | |
| (19,151) |
Loss from operations | | | (6,900) | | | (35,964) | | | 29,064 |
Interest income | | | 217 | | | 806 | | | (589) |
Interest expense | |
| (15) | |
| (23) | |
| 8 |
Change in fair value of embedded derivative | |
| 299,284 | |
| — | |
| 299,284 |
Foreign currency gain | |
| 1 | |
| 2 | |
| (1) |
Income (loss) before income taxes | |
| 292,587 | |
| (35,179) | |
| 327,766 |
Provision for income taxes | |
| (24,359) | |
| (202) | |
| (24,157) |
Net income (loss) attributable to common stockholders | | $ | 268,228 | | $ | (35,381) | | $ | 303,609 |
Mining Revenue
Mining revenue was $9.9 million for the nine months ended September 30, 2026, our first period of mining operations, and reflects 8,967.29 ZEC earned at an average fair value of $1,105.46 per ZEC. We had no revenue in the nine months ended September 30, 2025. Our production during the period was affected by the increase in total network hashrate, which reduced our share of network hashrate from approximately 18% at the commencement of mining to approximately 15% at September 30, 2026. Mining revenue is a non-cash item, as we received ZEC, not cash.
40
Cost of Revenue (excluding depreciation and amortization)
Cost of revenue was $0.9 million for the nine months ended September 30, 2026 and consisted of hosting costs, including electricity pass-through charges for 13,714 MWh consumed. We did not have any cost of revenue in the nine months ended September 30, 2025.
Research and Development Expenses
| | Nine Months Ended September 30, | | | | ||||
| | | | | | | | Increase | |
| | 2026 | | 2025 | | (Decrease) | |||
| | (in thousands) | | | | ||||
Direct research and development by program: | | | | | | | | | |
DKN-01 program | | $ | 591 | | $ | 23,970 | | $ | (23,379) |
FL-501 program | |
| — | |
| 725 | |
| (725) |
Total research and development expenses | | $ | 591 | | $ | 24,695 | | $ | (24,104) |
Research and development expenses were $0.6 million for the nine months ended September 30, 2026, compared to $24.7 million for the nine months ended September 30, 2025. The decrease of $24.1 million in research and development expenses during the nine months ended September 30, 2026 as compared to the same period in 2025, was primarily due to a decrease of $17.2 million in clinical trial and manufacturing costs, due to the completion of our clinical trials. In connection with the Company’s reduction in force in 2025, there was also a decrease of $5.9 million in payroll and other related expenses due to a decrease in headcount of our R&D full-time employees and a decrease of $1.0 million in stock based compensation expense due to forfeited stock options and no stock options granted in 2025 to R&D employees.
General and Administrative Expenses
General and administrative expenses were $14.1 million for the nine months ended September 30, 2026 compared to $6.7 million for the nine months ended September 30, 2025. The increase of $7.4 million in general and administrative expenses during the nine months ended September 30, 2026 as compared to the same period in 2025, was primarily due to a $5.5 million increase in stock based compensation expense due to RSUs granted to general and administrative employees and directors during the three months ended December 31, 2025 and during the nine months ended September 30, 2026. There was also an increase of $1.1 million in professional fees due to increased audit and financial consulting fees associated with digital assets and increased legal fees in connection with the Asset Purchase Agreement. Additionally, there was an increase of $0.5 million in insurance costs during the nine months ended September 30, 2026 as compared to the same period in 2025 and a $0.3 million increase in payroll and other related expenses as no incentive based compensation was recorded during the nine months ended September 30, 2025.
Depreciation and Amortization
Depreciation expense related to our mining equipment was $1.2 million for the nine months ended September 30, 2026, representing 44 days of depreciation of the mining machines that were acquired in the Mining Asset Acquisition on a straight-line basis over an estimated useful life of three (3) years.
Restructuring Charges
During the nine months ended September 30, 2025, we announced a workforce reduction involving approximately 75% of our workforce. As a result of this workforce reduction, during the nine months ended September 30, 2025, we incurred $4.5 million of charges, consisting primarily of one-time employee severance and benefit costs and stock based compensation expense related to acceleration of vesting.
Interest Income
During the nine months ended September 30, 2026 and 2025, we recorded interest income of $0.2 million and $0.8 million, respectively. The decrease was due to a higher average cash and cash equivalent balance during the nine months ended September 30, 2025.
41
Unrealized Gain on Change in Fair Value of Embedded Derivative
During the nine months ended September 30, 2026, we recorded a $299.3 million unrealized gain on the change in fair value of embedded derivative, as the price of ZEC increased from $508.18 per ZEC at December 31, 2025 to $1,414.56 per ZEC at September 30, 2026. We did not hold ZEC during the nine months ended September 30, 2025.
Foreign Currency Gain
During the nine months ended September 30, 2026 and 2025, we recorded an immaterial amount of foreign currency transaction gains. Foreign currency transaction gains are due to changes in the Australian dollar exchange rate related to activities of the Australian entity.
Income Taxes
We recorded a provision for income taxes of $24.4 million for the nine months ended September 30, 2026, compared to a provision of $0.2 million for the nine months ended September 30, 2025. The provision for the 2026 period consists principally of deferred income tax expense on the unrealized gain on the embedded derivative, partially offset by the benefit of net operating loss carryforwards.
Net Income (Loss)
As a result of the foregoing, we recorded net income of $268.2 million, or $1.42 per basic share and $1.17 per diluted share, for the nine months ended September 30, 2026, compared to a net loss of $35.4 million, or ($0.85) per basic and diluted share, for the nine months ended September 30, 2025.
Financial Position, Liquidity and Capital Resources
Since our inception, we have been engaged in organizational activities, including raising capital, and research and development activities. In October 2025, we implemented our digital asset treasury strategy and in August 2026, we commenced Zcash mining operations. Although we reported operating income for the three months ended September 30, 2026, we have never generated positive cash flows from its biopharmaceutical operations, and we do not yet have a product that has been approved by the FDA. Our mining revenue is received in ZEC, which we currently retain, while our hosting and other mining costs, our general and administrative expenses and the costs of our Leap operations are paid in cash. There is no assurance that profitable operations from our privacy technology/digital asset treasury strategy, our mining operations or our biotechnology operations, if achieved, could be sustained on a continuing basis. Further, our future operations are dependent on the success of efforts to raise additional capital, the success of our privacy technology/digital asset treasury strategy, our biotechnology research and commercialization efforts, regulatory approval, and, ultimately, the market acceptance of our products.
In accordance with ASC 205-40, Going Concern, we have evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued. As of September 30, 2026, we had cash and cash equivalents of $56.0 million and ZEC treasury holdings categorized as a digital asset receivable valued at $470.1 million. Additionally, we had accumulated deficit of $194.3 million at September 30, 2026 and during the nine months ended September 30, 2026, we had net income of $268.2 million. We believe that our cash and cash equivalents of $56.0 million as of September 30, 2026, together with our ability to raise additional capital from the $200.0 million Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co., will be sufficient to fund our operating expenses for at least the next 12 months from issuance of these financial statements.
In addition, to support our future operations, we will seek additional funding through public or private, equity or debt financings, and for our biotechnology operations, we will seek funding or development program cost-sharing through collaboration agreements or licenses with larger pharmaceutical or biotechnology companies. If we do not obtain additional funding or development program cost-sharing, we could be forced to eliminate certain programs, reduce or eliminate discretionary operating expenses, and delay company expansion, which could adversely affect our business prospects. The inability to obtain funding, as and when needed, could have a negative impact on our financial condition and our ability to pursue our business strategies.
42
Cash Flows
The following table summarizes our sources and uses of cash for each of the periods presented:
| | | | | | |
| | Nine Months Ended September 30, | ||||
| | 2026 | | 2025 | ||
| | (in thousands) | ||||
Cash used in operating activities | | $ | (9,024) | | $ | (37,283) |
Cash used in investing activities | | | (24,544) | | | — |
Cash provided by (used in) financing activities | |
| 75,501 | |
| (301) |
Effect of exchange rate changes on cash and cash equivalents | | | 20 | | | 21 |
Net increase (decrease) in cash and cash equivalents | | $ | 41,953 | | $ | (37,563) |
Operating activities. Net cash used in operating activities for the nine months ended September 30, 2026 was primarily related to a noncash unrealized gain on the change in fair value of embedded derivative of $299.3 million, revenue recognized from mining activities of $9.9 million, and changes in working capital, including an increase in deposits of $0.1 million, a decrease of $1.2 million in accounts payable and accrued expenses and a decrease in taxes payable of $0.4 million. These changes were partially offset by net income of $268.2 million, a change in deferred income taxes of $24.3 million, and changes in working capital, including a decrease of $0.6 million in research and development incentive receivable and a decrease of $0.8 million in prepaid expense and other assets. There was also noncash stock-based compensation expense of $6.8 million and depreciation expense of $1.2 million.
Net cash used in operating activities for the nine months ended September 30, 2025 was primarily related to our net loss from the operation of our business of $35.4 million and net changes in working capital, including a decrease in accounts payable and accrued expenses of $5.7 million and a decrease in lease liabilities of $0.2 million. These changes were partially offset by a decrease of $0.8 million in prepaid expenses and other assets, a decrease of $0.2 million in right-of-use asset and noncash stock-based compensation expense of $3.0 million.
Investing Activities. Net cash used in investing activities for the nine months ended September 30, 2026 was related to $13.5 million of cash used to purchase ZEC, a $6.0 million advanced payment to Bitmain for mining equipment, and $5.0 million used for the investment in Znewco, Inc. (“Znewco”), doing business as ZODL, through a SAFE. There were no investing activities during the nine months ended September 30, 2025.
Financing Activities. Net cash provided by financing activities during the nine months ended September 30, 2026, consisted of $75.7 million in net proceeds through issuance of common stock through ATM sales, $0.8 million of proceeds upon the exercise of stock options and the collection of stock subscription receivable of $0.2 million, partially offset by payment of $0.7 million of deferred offering costs and $0.5 million of principal payments of insurance financing. Net cash used in financing activities for the nine months ended September 30, 2025 consisted of $0.3 million of principal payments of insurance financing, partially offset by an immaterial amount of proceeds upon the exercise of stock options.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Not Applicable.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is (1) recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and (2) accumulated and communicated to our management, including our President and Chief Executive Officer, who is also serving as Chief Financial Officer and therefore currently serves as both our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
As of September 30, 2026, our management, with the participation of our Chief Executive Officer, who is also serving as Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway
43
Commission (COSO) in Internal Control—Integrated Framework (2013 Framework). Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. As previously reported in our Annual Report on Form 10-K filed on March 16, 2026, we identified a material weakness in our internal control over financial reporting. Because this material weakness remained unremediated as of September 30, 2026, management concluded that our disclosure controls and procedures were not effective as of that date. Management, with the oversight of the Audit Committee, is implementing a remediation plan that includes developing and implementing additional training for current personnel, improving review and monitoring controls, and engaging third party technical accounting resources to support the preparation, analysis, and review of financial information, particularly in areas involving complex accounting standards. The material weakness will not be considered to be remediated until the applicable controls have operated for a sufficient period of time and management has concluded, through testing, that they are operating effectively.
Changes in Internal Control over Financial Reporting
During the three months ended September 30, 2026, we commenced Zcash mining operations and implemented new processes and controls relating to the recognition of mining revenue and to the recording and verification of mining equipment and hosting invoices. Other than these changes and the activities described above, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that materially affected, or are reasonably likely to affect, internal control over financial reporting.
44
Part II — OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
An investment in our securities involves a high degree of risk. You should carefully consider the risk factors discussed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission (the “SEC”) on March 16, 2026 (the “Annual Report”), which could materially affect our business, financial condition, operating results, or cash flows. Except as set forth below, there have been no material changes to the risk factors disclosed in the Annual Report. The risk factors below supplement, and should be read together with, the risk factors in the Annual Report. In particular, the risk factors in the Annual Report relating to the price and liquidity of ZEC, the Zcash Network, the regulation of digital assets and privacy-enhancing digital assets, the custody of our ZEC, and our digital asset treasury strategy apply equally to the ZEC we earn through mining.
Risks Related to Our Zcash Mining Operations
We recently commenced Zcash mining operations, and have a limited operating history in the digital asset mining business. There can be no assurance that we will be able to realize the benefits we anticipate from these operations, which in turn could adversely affect our business, results of operations and financial condition.
On August 17, 2026, Cypherpunk Mining LLC (“Cypherpunk Mining”), our wholly owned subsidiary, acquired from Moria Mining, LLC (“Moria”), an affiliate of Winklevoss Treasury Investments, LLC (“Winklevoss Capital”), Bitmain Antminer Z15 Pro Zcash mining machines, the colocation and hosting agreements under which the machines are installed at three third-party hosting facilities in Texas, Tennessee, and West Virginia, and the related deposits for an aggregate purchase price of $33.3 million, which was paid through the issuance of a pre-funded warrant to Winklevoss Capital to purchase 43,290,042 shares of our common stock (measured for accounting purposes at $30.5 million, the fair value of the warrant on the closing date) (collectively, the “Mining Asset Acquisition”). Before the Mining Asset Acquisition, we had never operated a digital asset mining business, and our results for the quarter ended September 30, 2026 reflect only approximately six weeks of mining operations. In addition, our existing management team has limited experience operating, maintaining, and financing a mining fleet and managing hosting providers and equipment manufacturers, and we depend on a small number of personnel, including our Head of Mining, for these functions.
Due to our limited operating history and personnel resources, we may encounter problems, expenses, difficulties, complications and delays in conducting our mining operations. Specifically, we may fail to maintain the uptime, hosting rates, and fleet efficiency assumed when the transaction was approved or to establish the operational, financial reporting, and internal control processes that a mining business requires. If the acquired assets perform below our expectations, if Zcash mining economics deteriorate, or if we are unable to manage the business effectively, our results of operations and financial condition could be materially and adversely affected, and we could be required to record impairment charges with respect to the acquired machines. Consequently, there can be no assurance that we will be able to operate or expand our mining operations or realize the benefits we anticipate from these operations, which in turn could materially adversely affect our business, results of operations and financial condition.
Our mining revenue depends on factors that we do not control, principally the price of ZEC, which has been, and may continue to be highly volatile, the total computing power devoted to the Zcash Network, and the amount of ZEC awarded to miners.
Under the Zcash protocol, miners compete to solve blocks, and the probability that our machines earn a share of the block reward is approximately proportional to the computing power, or “hashrate,” we contribute relative to the total hashrate of the Zcash Network. Mining revenue per unit of hashrate (sometimes referred to as “hashprice”) is a function of the price of ZEC, network hashrate and difficulty, the block subsidy and transaction fees, and the payout method and fees of the mining pool we use. Each of these factors is outside our control and changes continuously.
45
Zcash network hashrate has grown rapidly. At the closing of the Mining Asset Acquisition, our fleet of approximately 4.2 GSol/s represented approximately 18% of total Zcash network hashrate. By September 30, 2026, Zcash network hashrate had increased to approximately 28 GSol/s and our share had declined to approximately 15%. Other miners have publicly announced orders for thousands of additional Z15 Pro machines scheduled for delivery in the fourth quarter of 2026 and allocations of Bitmain’s next-generation Zcash mining machines. We expect Zcash network hashrate to continue to increase significantly. Unless we add hashrate at least as fast as the Zcash network grows, our share of block rewards, and the amount of ZEC we mine, will decline even if our fleet operates at full capacity.
The price of ZEC has been and may continue to be extremely volatile. ZEC traded between approximately $26.14 and $736.51 during 2025 and between approximately $400 and $1,660 during the quarter ended September 30, 2026. Because our hosting, power, and other mining costs are denominated in U.S. dollars, a decline in the price of ZEC reduces the dollar value of the ZEC we mine without any corresponding reduction in our costs. A sustained decline in the price of ZEC could cause our mining operations to become unprofitable, in which case we may idle machines or discontinue mining. Estimates of mining revenue or profitability that we or third parties have published, including estimates of revenue per machine or per megawatt-hour, are based on prevailing ZEC prices and network conditions at a point in time, and should not be relied upon as an indication of future results.
The amount of ZEC awarded to miners is fixed by the Zcash protocol, will be reduced by approximately 50% at the next “halving,” currently expected in approximately November 2028, and is subject to a protocol-level allocation to development funding that can be changed.
Zcash has a fixed maximum supply of 21 million ZEC. New ZEC is created only through the block subsidy, which is reduced by half at predetermined block heights. Following the activation of NU7 on November 5, 2026, blocks are currently targeted every 25 seconds and the block subsidy is currently 0.52083333 ZEC per block, one-third of the 1.5625 ZEC per 75 second block in effect before NU7, of which 80% (0.41666668 ZEC per block, or approximately 1,440 ZEC per day across the entire network, the same daily amount as before NU7) is paid to miners and 20% is allocated under the protocol’s consensus rules to development funding. The next halving is expected to occur in or around November 2028, when the miners’ share of the subsidy will decline to 0.2083 ZEC per block, or approximately 720 ZEC per day across the entire network. Unless the price of ZEC or transaction fees increase sufficiently to offset the reduction, or we reduce our costs, our mining revenue measured in ZEC will decline by approximately half at that time, and our mining operations could become unprofitable.
Transaction fees have historically represented a small portion of Zcash mining revenue. Under the “Network Sustainability Mechanism” implemented in NU7, 60% of transaction fees are removed from circulation and are reissued to miners through future block subsidies only beginning in approximately February 2031. The allocation of the block subsidy between miners and development funding, the halving schedule, and the block interval are all consensus rules that can be changed through network upgrades that we do not control. Although coinholders voted in September 2026 to retain the existing halving schedule rather than adopt a “smoothed” issuance curve, future upgrades could reduce the share of issuance paid to miners, accelerate the decline in issuance, or change the mechanism by which miners are compensated.
Changes to the Zcash protocol, including the reduction in block time implemented in NU7 or a change to or abandonment of the Equihash algorithm, could reduce the value of our mining machines or render them obsolete.
Our mining machines are application-specific integrated circuit (“ASIC”) devices designed solely to perform the Equihash proof-of-work algorithm used by the Zcash Network. They cannot be used to mine digital assets that use other algorithms or for other computing purposes, and the other digital assets that use Equihash have substantially lower market values than ZEC. The Zcash protocol is developed and maintained by several independent organizations, including Zcash Open Development Labs (“ZODL”), Valar Group, Tachyon Group, Shielded Labs, the Zcash Foundation, and others, and is changed through network upgrades whose adoption depends on node operators, miners, and advisory votes of ZEC holders. Although we hold a meaningful amount of ZEC, we cannot determine the outcome of those votes or the content of network upgrades.
In September 2026, ZEC holders voted overwhelmingly in favor of reducing the target block interval from 75 seconds to 25 seconds, and NU7, which implemented that change, was activated on November 5, 2026. NU7 did not change the amount of ZEC issued to miners each day, but it required changes to the mining pool and node software and is expected to increase the rate at which blocks found by our machines are orphaned or rejected, which could reduce our effective hashrate and revenue of all miners, including us, until pool, node, and firmware software are optimized for the shorter interval. If any upgrade reduces the share of block rewards paid to proof-of-work miners, modifies the Equihash algorithm, or eliminates proof-of-work entirely (as the Ethereum network did in 2022), the value of our mining machines could be substantially impaired and our mining business could become unviable.
46
Network upgrades also carry execution risk. In May 2026, a vulnerability affecting the Orchard shielded pool was disclosed, leading to a temporary disabling of that pool, an emergency protocol upgrade and, in July 2026, the “Ironwood” upgrade that retired the Orchard pool behind a “turnstile.” The price of ZEC declined by more than 40% following this disclosure, even though it has since recovered. Similar events could reduce the price of ZEC and the value of the ZEC that we mine.
All of our mining machines are located at three third-party hosting facilities under agreements we acquired in the Mining Asset Acquisition, and we depend on our hosting providers for power, infrastructure, security, and the day-to-day operation of our fleet.
We do not currently own or operate any mining facility. Our machines are installed at hosting facilities in Texas, Tennessee, and West Virginia that are owned or operated by three unaffiliated hosting providers under colocation and hosting agreements entered into by Moria in 2026 and novated to Cypherpunk Mining at the closing of the Mining Asset Acquisition. Under these agreements, the hosting provider procures electricity, provides rack space, cooling, network connectivity, physical security and on-site technicians, and installs, monitors, maintains, and repairs our machines in exchange for fees based principally on the electricity consumed by our machines. The agreements have initial terms expiring in mid-2027. Our hosting providers are privately held companies of limited size and financial resources, and we have limited operating history with them.
If a hosting provider fails to perform, experiences financial distress or insolvency, loses its own power supply, site lease, or interconnection rights, becomes subject to a regulatory, zoning, permitting, or community action, suffers a fire, flood, storm, theft, or equipment failure, or terminates or declines to renew our agreement, our machines could be offline for an extended period, damaged or lost, or difficult and costly to recover and relocate. Furthermore, our contractual remedies in these situations may be limited, and deposits and prepaid amounts we hold with our hosting providers may not be recoverable. Hosting capacity suitable for ASIC mining is in increasingly short supply as power-intensive artificial intelligence and high-performance computing workloads compete for the same sites and interconnections. We may be unable to obtain replacement or additional hosting capacity on acceptable terms or at all. The concentration of our fleet at the three sites means that an event affecting any one site could reduce our hashrate by a substantial proportion. Any of these events could materially reduce our mining revenue.
Our mining operations require substantial, reliable, and low-cost electricity, and increases in power costs, curtailment, and outages at our hosting sites could reduce or eliminate our mining margins.
Electricity is the principal cost of mining, and our hosting fees are largely a function of the power our machines consume. Power prices at our hosting sites are affected by wholesale market conditions, weather, fuel costs, transmission constraints, regulatory and tariff changes, and the rapidly growing demand of data centers. Furthermore, our Texas site is located within the Electric Reliability Council of Texas (“ERCOT”) market, in which large flexible loads such as mining facilities are subject to curtailment instructions and demand-response programs during periods of grid stress and to an evolving regulatory regime for large loads. Specifically, in September 2026, the Governor of Texas directed state environmental regulators to pause permitting of data-center projects pending an ERCOT audit of large-load interconnections. Our Tennessee and West Virginia sites depend on a limited number of utilities and transmission providers.
Curtailment, whether voluntary or mandatory, reduces the time our machines operate, and any demand-response or similar payments received by our hosting providers may not be shared with us or may not offset lost mining revenue. Extended outages, equipment failures, severe weather, and natural disasters at a site could halt mining and damage our machines. Because our revenue is determined by factors outside our control while a significant portion of our hosting costs is fixed or semi-fixed, increases in power costs, curtailment, and downtime have a disproportionate effect on our margins and could cause our mining operations to generate losses.
Our fleet consists of a single model of mining machine from a single manufacturer, which exposes us to obsolescence, supply, warranty, repair, and design-flaw risks.
Since August 2026, all of our mining machines are Bitmain Antminer Z15 Pro units, which were the most efficient Zcash mining machines commercially available at the time of the Mining Asset Acquisition. Bitmain Technologies Delaware Limited, together with its affiliates (“Bitmain”), is currently the only manufacturer capable of supplying Equihash ASIC miners in commercial quantities. Bitmain is currently developing a next-generation Zcash miner. When more efficient machines are delivered to other miners, network hashrate and difficulty will increase and the share of block rewards earned by our existing fleet will fall. As our fleet ages, its efficiency relative to the network will decline until the machines are no longer economic to operate, at which point we would need to replace them at substantial cost or reduce or discontinue our mining operations.
47
Mining machines are subject to wear, component failure (particularly hashboards and power supply units), heat, and power events. Repair capacity, spare parts, and authorized service for Equihash miners are limited in the United States (the “U.S.”), and the manufacturer’s warranty on our machines, which we acquired from Moria, may have expired or be expiring soon. A design or firmware defect affecting the Z15 Pro model or a dispute with the manufacturer regarding the product could affect a majority of, or all, of our fleet at once and harm our reputation and business. Any interruption, delay or system failure could result in financial losses, a decrease in the trading price of our common stock and damage to our reputation. Furthermore, we have no ability to influence the manufacturer’s product roadmap, pricing, or allocation of new machines among customers, and the manufacturer may itself mine ZEC or supply our competitors on more favorable terms. If we are not able to obtain a sufficient number of mining machines at favorable prices, our growth expectations, liquidity, financial condition and results of operations may be negatively impacted.
We have expressed an interest to purchase next-generation Zcash mining machines from Bitmain under a letter of intent and have paid a substantial deposit. However, we may decide not to purchase the machines or may not receive the machines on the timetable, at the price, or with the performance we expect, or at all.
In September 2026, Cypherpunk Mining entered into a letter of intent with Bitmain for the purchase of Bitmain’s next-generation Zcash mining machines with a total purchase commitment of up to $30 million, and paid a deposit of $6 million. The letter of intent is non-binding in most respects, because the machines have not been publicly announced. The machines’ specifications, unit price, and delivery schedule will be fixed only when Bitmain announces the product, at which time, we will have a short period to decide if we want to execute a definitive purchase agreement with Bitmain. The priority supply allocation we have been granted is non-exclusive and is shared with other customers that have made similar commitments. If we do not execute a definitive agreement with Bitmain within the specified time frame, or if Bitmain does not enter into a definitive agreement with us, our principal remedy is the return of our deposit without interest.
If we proceed with the purchase of the machines, we will be required to fund the remaining purchase price in installments before delivery. Our purchase of the machines involves risks outside of our control, including, among other things, the risk that the machines may be delivered late, may not perform to specification, or may be surpassed by competing products. We may also bear import tariffs, duties, and compliance risks that expose us to potential litigation and disputes regarding violation. Any of these outcomes or issues could delay or prevent the expansion of our hashrate, cause us to lose share of network hashrate to competitors who receive new machines earlier, and adversely affect our results of operations and financial performance.
The mining machines we purchase are manufactured outside the U.S. and are subject to tariffs, customs detention, and other trade and import risks that may have a material adverse impact on our business, financial condition and results of operations.
Bitmain manufactures its machines in China and Southeast Asia and sells to U.S. customers. If we serve as importer of record for the machines we have committed to purchase, we will be responsible for the classification, valuation, and declaration of the imported machines, for payment of all applicable duties, including under Section 301 of the Trade Act of 1974, and reciprocal or country-specific tariffs whose rates have changed frequently and could increase substantially, and for compliance with U.S. Customs and Border Protection (“CBP”) requirements, Federal Communications Commission equipment-authorization and labeling rules, the Uyghur Forced Labor Prevention Act, and U.S. sanctions and export-control laws. CBP has in recent years detained shipments of cryptocurrency mining machines for extended periods over equipment-authorization and component-origin questions, and the tariff classification of mining machines has not been applied uniformly. Tariff increases could materially raise the cost of our planned purchases, and detentions or seizures could delay deployment or result in the loss of machines. Restrictions on the export of mining equipment or semiconductors from China or other countries, or on their importation into the U.S., could prevent us from obtaining machines at all, which could adversely affect our business, financial condition and results of operations.
We depend on a third-party mining pool to earn and receive mining rewards, and the concentration of Zcash hashrate among a small number of pools and miners heightens network risks.
We do not mine blocks independently. We direct our hashrate to third-party mining pools that aggregate the hashrate of many miners, receive block rewards and transaction fees, and pay participants in proportion to their contributed work under the pool’s payout method. We rely on each pool to measure our contribution accurately, to calculate and remit payouts, to maintain its systems against cyberattack and failure, and to comply with applicable law. Our ability to audit a pool’s calculations or to recover underpayments is limited, and payouts that have accrued but not yet been remitted are exposed to the pool’s credit and operational risk. A pool may change its fees, payout method or participation terms, suspend operations, or cease accepting our hashrate on little notice. The number of pools with sufficient Zcash hashrate and acceptable compliance practices is relatively small.
48
We compete with other Zcash miners, including miners that own their infrastructure, have lower power costs and larger fleets, and have committed access to next-generation equipment, and we may be unable to maintain our share of network hashrate.
Zcash mining is competitive and is becoming more so as the price of ZEC has increased. Other publicly disclosed Zcash miners operate owned data centers, have announced purchases of thousands of Z15 Pro machines and allocations of up to $100 million of next-generation machines, and have access to affiliated financing and mining-pool infrastructure. Mining pool operators, hosting providers, and equipment manufacturers may also mine for their own account. Many of these competitors have greater financial resources, lower power costs, more operating experience, and better access to equipment than we do. We also compete with bitcoin miners and with artificial intelligence and high-performance computing operators for hosting capacity and power. If we are unable to obtain new machines, hosting capacity, or capital on competitive terms, our share of network hashrate and our mining revenue, our profitability, and the results of our operations will decline.
Our mining operations expose us to regulatory, tax, energy, and environmental risks.
In addition to the regulatory risks relating to ZEC and privacy-enhancing digital assets described in the Annual Report, the mining of ZEC is itself the subject of evolving regulation. Although the SEC and the CFTC issued a joint interpretive release on March 17, 2026 stating that protocol-level mining, including pooled mining, generally does not involve the offer or sale of a security, the release is not binding law and may be revised or withdrawn. Federal, state, and local governments have proposed or adopted measures directed at digital asset mining and large electrical loads, including moratoria and bans on mining or data-center development, zoning and noise ordinances, excise taxes on mining, mandatory energy-use reporting and restrictions on grid interconnection, and measures aimed at hyperscale artificial-intelligence data centers may be applied to mining facilities. Any such measure affecting one of our hosting sites could require the relocation or shutdown of our machines. Because Zcash is a privacy-enhancing digital asset, regulators may apply heightened scrutiny to mining companies.
The U.S. federal income tax treatment of mining rewards is unsettled. Under current IRS guidance, rewards are ordinary income at their fair market value when received, with gain or loss recognized again on disposition, which could require us to pay cash taxes on ZEC we continue to hold. The location of our machines in Texas, Tennessee, and West Virginia subjects us to state and local income, franchise, sales and use, and property taxes. Our hosting providers are subject to environmental, energy, and climate-related laws and regulations, the costs of which may be passed through to us. Adverse publicity regarding the energy consumption of digital asset mining could harm our reputation or lead to regulation that increases our costs.
Our mining machines and the ZEC we mine are subject to a variety of risks related to loss, theft, and cyberattack, and our insurance may not be adequate to cover the losses we suffer.
Our machines are located at facilities we do not control, and their physical security depends on our hosting providers. We maintain limited property insurance on the machines, but our insurance may not be adequate to cover the losses we suffer as a result of certain events such as (i) the presence of construction or repair defects or other structural or building damage, (ii) any noncompliance with or liabilities under applicable environmental, health or safety regulations or requirements or building permit requirements, (iii) any damage resulting from natural disasters, such as hurricanes, earthquakes, fires, floods, and (iv) windstorms, and claims by employees and others for injuries sustained at our properties. Our hosting providers’ insurance may also not cover loss of or damage to customer equipment. Mining machines are also exposed to firmware and remote-management vulnerabilities, including attacks that redirect a machine’s hashrate to an attacker’s pool account, and our pool account credentials, wallets, and the ZEC in transit from the pool to our custodian are targets for theft. Mined ZEC is remitted by the pool to addresses of our custodian, Gemini. Errors or compromises in that process could result in the irreversible loss of ZEC. The limited-recourse, custody, and cybersecurity risks described in the Annual Report apply to the ZEC we mine, and in the event of an uninsured loss, including a loss that exceeds any insurance recovery limit, at any of the facilities, such mines may not be adequately repaired in a timely manner or at all and we may lose some or all of the future revenues anticipated to be derived from such mines.
We depend on a small number of personnel for our mining operations.
Our mining business is managed by our Head of Mining, who joined us in August 2026, with a small number of personnel, and it depends on the technicians employed by our hosting providers. Competition for personnel with digital asset mining expertise is intense. The loss of our Head of Mining or other key personnel, or our inability to hire additional qualified personnel as the business grows, could disrupt our operations, delay the deployment of new machines and adversely affect our results of operations.
49
Affiliates of Winklevoss Capital have interests in the Zcash ecosystem and in transactions with us that may conflict with the interests of our other stockholders. The pre-funded warrant issued in the Mining Asset Acquisition may result in substantial dilution of our common stock.
We acquired our mining fleet from an affiliate of Winklevoss Capital and custody of our ZEC with Gemini, an affiliate of Winklevoss Capital. Furthermore, we have two directors who were originally designated by Winklevoss Capital. Affiliates of Winklevoss Capital that continue to develop, own, or finance Zcash ecosystem assets have filed a registration statement with the SEC to establish a Zcash Exchange Traded Fund that would hold ZEC, and may have interests that differ from ours or our other stockholders. The pre-funded warrant issued to WTI is exercisable at any time at a nominal price for up to 43,290,042 shares, subject to a 19.99% beneficial ownership limitation. We have agreed to seek stockholder approval at our next annual meeting for issuances above approximately 4.99% of our outstanding shares as required by Nasdaq rules and to register the resale of the warrant shares. The exercise of the pre-funded warrant and the resale of the underlying shares could substantially dilute our stockholders, and the increase in WTI’s ownership may contribute to our becoming a “controlled company” as described in the Annual Report.
Risks Related to the Financial Performance and Accounting of Our Zcash Mining Business
Our mining results will fluctuate significantly from period to period, and our results for the partial quarter ended September 30, 2026 are not indicative of future performance.
Our mining revenue in any period depends on the number of machines online, their uptime, network hashrate and difficulty, the price of ZEC, mining pool performance and fees, and curtailment, each of which varies from day to day. Our results for the quarter ended September 30, 2026 reflect approximately six weeks of operations during a period in which the price of ZEC tripled for a time and network hashrate increased by approximately 20%. These results are not indicative of the results we would have reported for a full quarter or will report in future periods. Period-to-period comparisons of our mining results should not be relied upon as an indication of future performance. Quarterly fluctuations in mining revenue, mining margins, and the fair value of our ZEC will cause volatility in our reported results and in the market price of our common stock.
Our mining costs are payable in U.S. dollars while our mining revenue is received in ZEC, which could require us to sell ZEC at unfavorable prices or raise additional capital.
Our hosting fees, which are our principal mining cost, are invoiced in U.S. dollars, as are insurance, personnel costs, and the purchase price of new machines, while the mining rewards we receive are denominated in ZEC, which we call Zcash flow. Our objective is to hold the ZEC we mine, as part of our digital asset treasury strategy and to fund our U.S. dollar denominated mining costs from cash on hand and the proceeds of equity offerings, including sales under our at-the-market program. If the price of ZEC declines, if our cash resources are insufficient, or if equity financing is unavailable or excessively dilutive, we may be required to sell mined or treasury ZEC at depressed prices to meet our obligations, which could depress the market price of ZEC and could result in realized gains or losses, or to sell equity in a dilutive transaction or at a discount, which could depress the price of our stock.
Changes in the price of ZEC or in accounting guidance could cause our reported results to be volatile and could result in impairment charges.
We recognize revenue from mining as the fair value of the ZEC we receive from the pool each day, which means that revenue recognized in U.S. dollars each day for the same number of ZEC will vary daily with the price of ZEC. Our held ZEC from mining is then accounted for under the digital assets receivable model, under which the receivable is a hybrid instrument whose embedded derivative is remeasured at fair value each period. As a result, both our mining revenue and the subsequent remeasurement of mined ZEC will introduce volatility into our reported results that does not correspond to the U.S. dollar value of the ZEC at the time it was generated by mining. The mining machines are recorded at their allocated cost of $30.0 million, based on the fair value of the consideration paid, and depreciated over an estimated useful life of three years, and they are subject to impairment testing whenever events indicate that their carrying amount may not be recoverable; any impairment would be recorded as a non-cash charge. The accounting for digital asset mining, including the measurement date for noncash consideration, the treatment of pool payouts, and the accounting for deposits and prepayments to equipment manufacturers and hosting providers, continues to evolve, and changes in authoritative guidance, SEC staff views, or our own judgments could require us to change our accounting, restate prior periods, or report results that are not comparable with prior periods or with other companies.
50
Our mining revenue is derived entirely from a single digital asset.
All of our mining revenue is received in ZEC, and the fair value of our ZEC holdings, including mined ZEC, represents a substantial majority of our total assets. We do not currently hedge the price of ZEC or our expected mining production, and the market for ZEC derivatives is limited. The concentration of both our treasury and our Zcash flow operating revenue in ZEC means that a sustained decline in the price of ZEC would simultaneously reduce the value of our assets and have a material adverse effect on our revenue, Zcash flow, and results of operations, and could have a material adverse effect on our stock price.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The information required by this Item with respect to the issuance of the August 2026 Pre-Funded Warrant to WTI as consideration in the Mining Asset Acquisition was previously reported in our Current Report on Form 8-K filed with the SEC on August 17, 2026.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
(c) Rule 10b5-1 Trading Plan
During the three months ended September 30, 2026, no director or officer of the Company
51
Item 6. Exhibits
See the Exhibit Index immediately prior to the signature page to this Quarterly Report on Form 10-Q for a list of exhibits filed or furnished with this report, which Exhibit Index is incorporated herein by reference.
EXHIBIT INDEX
1.1 | | Asset Purchase Agreement, dated August 17, 2026, by and among the Company, Moria Mining, LLC, Winklevoss Treasury Investments, LLC and Cypherpunk Mining LLC (incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K, as filed on August 18, 2026). |
| | |
4.1 | | Form of Pre-Funded Warrant to Purchase Common Stock (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, as filed on August 18, 2026). |
| | |
10.1 | | First Amendment to Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, as filed on August 18, 2026). |
| | |
10.2 | | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, as filed on September 22, 2026). |
| | |
31.1* | | Certification of Chief Executive Officer and Chief Financial Officer Required Under Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | |
32.1* | | Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| | |
101* | | The following materials from Cypherpunk Technologies Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets at September 30, 2026 and December 31, 2025, (ii) Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 2025, (iii) Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2026 and 2025, (iv) Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2026 and 2025, (v) Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025, and (vi) Notes to the Condensed Consolidated Financial Statements, tagged as blocks of text. |
| | |
104* | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
* Filed herewith.
**Furnished with this report.
52
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | CYPHERPUNK TECHNOLOGIES INC. | |
| | | |
Date: November 13, 2026 | | By: | /s/ Douglas E. Onsi |
| | | Douglas E. Onsi |
| | | President, Chief Executive Officer and Chief Financial Officer |
| | | (Principal Executive Officer, Principal Financial Officer and Duly |
| | | Authorized Signatory) |
53